CN109731045A - For inhibiting the Chinese medicine composition of growth of tumour cell prophylactic treatment cancer - Google Patents

For inhibiting the Chinese medicine composition of growth of tumour cell prophylactic treatment cancer Download PDF

Info

Publication number
CN109731045A
CN109731045A CN201910214558.2A CN201910214558A CN109731045A CN 109731045 A CN109731045 A CN 109731045A CN 201910214558 A CN201910214558 A CN 201910214558A CN 109731045 A CN109731045 A CN 109731045A
Authority
CN
China
Prior art keywords
weight
parts
blood
purified water
donkey
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201910214558.2A
Other languages
Chinese (zh)
Inventor
傅金荣
付金洪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianyuan Jiangxi Pharmaceutical Co Ltd
Original Assignee
Tianyuan Jiangxi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianyuan Jiangxi Pharmaceutical Co Ltd filed Critical Tianyuan Jiangxi Pharmaceutical Co Ltd
Priority to CN201910214558.2A priority Critical patent/CN109731045A/en
Publication of CN109731045A publication Critical patent/CN109731045A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to for inhibiting the Chinese medicine composition and preparation process of growth of tumour cell prophylactic treatment cancer.Specifically, it relates in one aspect to the Chinese medicine composition made of Radix Astragali, Radix Angelicae Sinensis, Rehmannia glutinosa, Radix Codonopsis, donkey-hide gelatin, ferrous gluconate and optional pharmaceutic adjuvant and is made of 1200 parts by weight of Radix Astragali, 400~600 parts by weight of Radix Angelicae Sinensis, 300~500 parts by weight of Rehmannia glutinosa, 300~500 parts by weight of Radix Codonopsis, 100~300 parts by weight of donkey-hide gelatin, 20~40 parts by weight of ferrous gluconate and optional pharmaceutic adjuvant preparing the purposes in product for inhibiting growth of tumour cell prophylactic treatment cancer, the Chinese medicine composition.The method for further relating to the Chinese medicine composition.The traditional chinese medicine composition of the invention has excellent biology effect in terms of for inhibiting growth of tumour cell prophylactic treatment cancer.

Description

Chinese medicinal composition for inhibiting tumor cell growth, preventing and treating cancer
Technical Field
The invention belongs to the field of medical health products, relates to a traditional Chinese medicine composition for improving qi and blood functions of a human body, improving anoxia resistance and delaying senescence, a traditional Chinese medicine composition for inhibiting tumor cell growth and preventing and treating cancers, a preparation process and a detection method of the traditional Chinese medicine composition, and particularly relates to a traditional Chinese medicine composition which is used for improving qi and blood functions of the human body, improving anoxia resistance and delaying senescence, and is used for inhibiting tumor cell growth and preventing and treating cancers and can be called as Hairikang brand radix astragali, angelica sinensis and donkey-hide gelatin oral liquid, a preparation method and a detection method of the traditional Chinese medicine composition.
Background
Nutritional anemia is divided into small cell anemia and large cell anemia. The former is also called iron deficiency anemia and is mostly developed in infants and children; the latter is also called megaloblastic anemia, whose cause is the lack of factors that mature red blood cells.
In traditional Chinese medicine, nutritional anemia belongs to the category of 'blood deficiency' and 'consumptive disease', blood is considered to come from the spleen, is fundamentally in the kidney and relates to the heart and the liver, and if the spleen and the stomach are weak, food essence cannot be cured, the source of vital energy and blood is insufficient, and anemia is generated. The blood-enriching agent is a kind of prescription based on the theory of "reinforcing the body by deficiency and damaging the body by deficiency" in the "Nei Jing". Therefore, the formula is usually combined with qi tonics to achieve the effect of tonifying qi and generating blood. Cheng is as in Wen Bing tiao Bian (treatise on blood by differentiation and treatment of Wen Bing): for blood deficiency, it can tonify qi and promote blood generation. Kidneys store essence, essence generates marrow, and marrow generates blood, so there is the saying that the source of blood lies in the kidneys. The Hairikang Xueerhong oral liquid is a health food prepared from astragalus root, angelica, prepared rehmannia root, radix codonopsitis, donkey-hide gelatin and ferrous gluconate as raw materials, and has the health care function of improving nutritional anemia as proved by functional tests.
The anemia is a common disease among residents in China, is also a global disease, is the most widely affected object, and comprises children, teenagers, adult men and women, particularly pregnant women, nursing mothers and children, the main six manifestations of nutritional anemia are that ① is slow in onset, the skin mucosa is generally found to be gradually pale, particularly lips and nail beds are most obvious, ② is tired and powerless, activities are not lovely, dysphoria is frequent or cachexia is frequent, ③ is anorexia, vomiting or diarrhea is frequent, pica occurs in some children, when a ④ doctor examines, the liver and spleen of the children are swollen, the heart rate is increased quickly, hemoglobin is reduced in the examination, when the ⑤ patient looks are fattened, thin and yellow hair, pale and yellow complexion, fatigue and weakness, inappetence are frequent, and ⑥ is lagged in intelligence and movement, and even gradually recedes.
Nutritional anemia is one of nutritional deficiency diseases with the highest incidence worldwide, and according to the survey of the world health organization (WTO) on nutritional anemia in 50 hundred million people worldwide, about 10-30% of people worldwide have iron deficiency in different degrees, namely 10 hundred million people. The incidence rate of the anemia is very high in China, and the average incidence rate of the anemia caused by iron deficiency of Chinese residents is 13.6 percent as disclosed in the Chinese resident nutrition and health condition 2004; the prevalence rates of anemia of infants within two years old, the elderly over 60 years old and women of childbearing age are 21.7%, 18.5% and 20.6% respectively; the other group is that the incidence rate of iron deficiency anemia in China reaches 15-20%, the anemia rate of women and children reaches 20% due to iron deficiency, and iron deficiency is listed as one of four nutrient deficiency symptoms in the world by the world health organization (WTO). Therefore, the market demand of blood-enriching products is large.
When the body's demand and supply of iron are unbalanced, this leads to depletion of stored Iron (ID) in the body, followed by Iron Deficiency (IDE) in the red blood cells, which ultimately leads to Iron Deficiency Anemia (IDA). IDA is the final stage of iron deficiency (including ID, IDE and IDA) and manifests as iron deficiency-induced microcytic hypopigmented anemia and other abnormalities. IDA is the most common anemia. The incidence of the disease is obviously increased in developing countries, economically undeveloped areas, infants and women of childbearing age. Survey of people in Shanghai areas shows that: the annual incidence of iron deficiency is 75.0-82.5% of infants between 6 months and 2 years old, 66.7% of women above 3 months of gestation, 43.3% of women of childbearing age and 13.2% of teenagers between 10 years and 17 years old; the prevalence rates of IDA of the above people are 33.8-45.7%, 19.3%, 11.4% and 9.8%, respectively. Iron deficiency is mainly related to the following factors: inadequate supplementary food for infants, monophagia for teenagers, menorrhagia/multiple pregnancies/lactation for women, and certain pathological factors (such as gastrostaxis, chronic blood loss, chronic diarrhea, atrophic gastritis and hookworm infection). The multiple groups of iron deficiency anemia are infants and women of childbearing age. The common symptoms of iron deficiency anemia are weakness, easy fatigue, dizziness, headache, dim eyesight, tinnitus, palpitation and the like.
Common causes of iron deficiency anemia are chronic wasting diseases, malnutrition, hookworm infection and the like. In addition, the following causes are also common causes of iron deficiency anemia: 1. iron demand increases and iron intake is insufficient: it is common in infants, teenagers, pregnant and lactating women. Infants need more iron, and are easy to lack iron if eggs, meat and other supplementary foods with higher iron content are not supplemented. Teenagers are prone to iron deficiency when eating a partiality. Women with menorrhagia, pregnancy or lactation need increased iron amount, and IDA is easily caused if high-iron food is not supplemented. 2. Iron absorption disorder: after a gastrotomy, gastric acid is not secreted sufficiently and food rapidly enters the jejunum, bypassing the main absorption site of iron (duodenum), resulting in reduced iron absorption. In addition, IDA can occur due to iron malabsorption in gastrointestinal disorders caused by various causes, such as chronic diarrhea, chronic enteritis, crohn's disease, etc. 3. Excessive iron loss: IDA results from chronic long-term iron loss that is not corrected. Such as: chronic gastrointestinal bleeding (including hemorrhoids, gastroduodenal ulcer, hiatal hernia, polyps of digestive tract, gastrointestinal tumors, parasitic infection, esophageal/gastric fundal varices, and the like), menorrhagia (gynecological diseases such as intrauterine contraceptive ring placement, hysteromyoma, menstrual disorder, and the like), hemoptysis and alveolar hemorrhage (including hemosiderosis in lung, pulmonary hemorrhage-nephritis syndrome, tuberculosis, bronchiectasis, lung cancer, and the like), hemoglobinuria (paroxysmal nocturnal hemoglobinuria, cold antibody type autoimmune hemolysis, cardiac artificial valves, marching hemoglobinuria, and the like), and others (hereditary hemorrhagic telangiectasia, chronic renal failure hemodialysis, multiple blood donations, and the like). From the condition of the blood-enriching products in the current market, the blood-enriching products mainly comprise two types: one is chemically synthesized components such as ferrous lactate, porphyrin iron, ferrous sulfate, ferrous citrate, ferrous gluconate, Vc and the like, and the treatment of anemia by taking the ferrous gluconate is a clinically efficient method at present; the other kind is animal and plant and Chinese herbal medicine components such as colla Corii Asini, Mel, gallus Domesticus, fructus Lycii, soybean phospholipid, Ginseng radix, radix Angelicae sinensis, and radix astragali. However, no product for enriching the blood by combining chemical synthesis components, animal and plant components and Chinese herbal medicine components is found in the market.
In addition, as is well known, the combined blood-enriching product can be used for improving hypoxia tolerance and delaying senility of human bodies and can also be used for inhibiting the growth of tumor cells and preventing and treating cancers.
Therefore, new blood-enriching products and methods are still expected in the art, in particular, products and methods for enriching blood by combining chemically synthesized components with animal, plant and Chinese herbal medicine components; in addition, based on the way of taking the blood-enriching product, the people who want to improve the qi and blood functions of the human body, improve the hypoxia tolerance, delay aging and inhibit the growth of tumor cells for preventing and treating cancers are also expected urgently by the technical personnel in the field.
Disclosure of Invention
The invention aims to provide a blood enriching product and a blood enriching method, which are used for improving the qi and blood functions of a human body, improving anoxia resistance, delaying senility and inhibiting the growth of tumor cells to prevent and treat cancers. Surprisingly, the traditional Chinese medicine composition which can be used for improving qi and blood functions of a human body, improving anoxia tolerance, delaying senescence and inhibiting tumor cell growth, preventing and treating cancers and is called as Hai Rui kang astragalus mongholicus and angelica donkey-hide gelatin oral liquid has excellent technical effects. The present invention has been completed based on this finding.
In a first aspect, the present invention provides a Chinese medicinal composition, which is prepared from astragalus root, Chinese angelica root, prepared rehmannia root, pilose asiabell root, donkey-hide gelatin, ferrous gluconate and optional pharmaceutic adjuvants.
The traditional Chinese medicine composition is prepared from 1200 parts by weight of astragalus membranaceus, 400-600 parts by weight of angelica sinensis, 300-500 parts by weight of prepared rehmannia root, 300-500 parts by weight of codonopsis pilosula, 100-300 parts by weight of donkey-hide gelatin, 20-40 parts by weight of ferrous gluconate and optional pharmaceutical excipients.
The traditional Chinese medicine composition is prepared from 1200 parts by weight of astragalus membranaceus, 400-600 parts by weight of angelica sinensis, 310-490 parts by weight of prepared rehmannia root, 300-500 parts by weight of codonopsis pilosula, 100-300 parts by weight of donkey-hide gelatin, 20-40 parts by weight of ferrous gluconate and optional pharmaceutical excipients.
The traditional Chinese medicine composition is prepared from 1200 parts by weight of astragalus membranaceus, 450-550 parts by weight of angelica sinensis, 350-450 parts by weight of prepared rehmannia root, 350-450 parts by weight of codonopsis pilosula, 150-250 parts by weight of donkey-hide gelatin, 25-35 parts by weight of ferrous gluconate and optional pharmaceutical excipients.
The traditional Chinese medicine composition according to the first aspect of the invention is prepared from 1200 parts by weight of astragalus membranaceus, 500 parts by weight of angelica sinensis, 400 parts by weight of prepared rehmannia root, 400 parts by weight of codonopsis pilosula, 200 parts by weight of donkey-hide gelatin, 32 parts by weight of ferrous gluconate and optional pharmaceutical excipients.
The Chinese medicinal composition according to the first aspect of the present invention is a liquid medicament in the form of an oral liquid.
The traditional Chinese medicine composition is a liquid medicament in the form of oral liquid, and is prepared by using 8-16 g of astragalus root medicinal material per 100 ml.
The traditional Chinese medicine composition is a liquid medicament in the form of oral liquid, and is prepared by using 10-14 g of astragalus mongholicus medicine per 100 ml.
The Chinese medicinal composition according to the first aspect of the present invention, which is a liquid medicament in the form of an oral liquid, is prepared in an amount of 12g per 100ml of the astragalus root material used.
The traditional Chinese medicine composition according to the first aspect of the present invention, wherein the pharmaceutical excipient comprises a flavoring agent. In one embodiment, the flavoring agent is a sweetener, such as aspartame, acesulfame k, sodium saccharin, sucrose (e.g., white granulated sugar), and the like. The amount of these sweeteners can be easily determined according to the specific variety of the use and experience of those skilled in the art, for example, the amount of aspartame, acesulfame k, saccharin sodium and the like is usually 0.05% to 1%, especially 0.1%, for example, sucrose (e.g., white granulated sugar) can account for 5 to 25%, for example 10 to 20%, for example 10%, 12%, 15%, 20% of the weight of the Chinese medicinal composition of the present invention. In particular, the amount of sweetener to be used may be determined according to, for example, preferences of the individual user, and the choice of sweetener to be used is well known to those skilled in the art, and its type and amount do not affect the physicochemical properties of the product.
The traditional Chinese medicine composition according to the first aspect of the present invention is a liquid medicament in the form of an oral liquid, which is prepared by a method comprising the steps of:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata and radix Codonopsis with purified water twice (for example, decocting 5-8 times (for example, 6 times) of purified water for 1-3 hr (for example, 2 hr), filtering to obtain filtrate, decocting the second residue with 5-8 times (for example, 6 times) of purified water for 1-3 hr (for example, 2 hr), filtering to obtain filtrate), and mixing the two filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 0.8-1.2: 1, such as 1: 1; adding ethanol (such as ethanol with concentration of 90% or more or 95% or more) to make ethanol content reach 55-65% (such as ethanol content reach 60%), standing for precipitating with ethanol for 20-30 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at the temperature of 60-80 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃) to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing donkey-hide gelatin into small pieces, adding 8-12 times, for example, 10 times of purified water, heating to completely dissolve the donkey-hide gelatin, and filtering for later use;
(5) mixing ferrous gluconate and optional flavoring agent (such as sucrose), adding 2-4 times of purified water (such as 3 times of purified water), and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, and sterilizing under hot pressure (such as 105 deg.C for 45 min).
The traditional Chinese medicine composition according to the first aspect of the invention, wherein the pharmaceutic adjuvant further comprises sodium citrate and sorbitol. In one embodiment, the weight ratio of the medicinal materials astragalus root and sodium citrate is 12: 0.1. in one embodiment, the weight ratio of the medicinal materials astragalus and sorbitol is 12: 0.5. in one embodiment, sodium citrate and sorbitol are added to the filtrate obtained in step (2).
The traditional Chinese medicine composition according to the first aspect of the invention, wherein the pharmaceutic adjuvant further comprises sodium tartrate and glycine. In one embodiment, the weight ratio of the medicinal materials astragalus root and sodium tartrate is 12: 0.25. in one embodiment, the weight ratio of the medicinal materials of astragalus and glycine is 12: 0.75. in one embodiment, sodium tartrate and glycine are added to the filtrate obtained in step (2).
Further, the present invention provides a method for preparing a Chinese medicinal composition, for example, the Chinese medicinal composition of any embodiment of the first aspect of the present invention, which is prepared from astragalus root, angelica root, prepared rehmannia root, codonopsis pilosula, donkey-hide gelatin, ferrous gluconate and optionally pharmaceutical excipients; the method comprises the following steps:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata and radix Codonopsis with purified water twice (for example, decocting 5-8 times (for example, 6 times) of purified water for 1-3 hr (for example, 2 hr), filtering to obtain filtrate, decocting the second residue with 5-8 times (for example, 6 times) of purified water for 1-3 hr (for example, 2 hr), filtering to obtain filtrate), and mixing the two filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 0.8-1.2: 1, such as 1: 1; adding ethanol (such as ethanol with concentration of 90% or more or 95% or more) to make ethanol content reach 55-65% (such as ethanol content reach 60%), standing for precipitating with ethanol for 20-30 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at the temperature of 60-80 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃) to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing donkey-hide gelatin into small pieces, adding 8-12 times, for example, 10 times of purified water, heating to completely dissolve the donkey-hide gelatin, and filtering for later use;
(5) mixing ferrous gluconate and optional flavoring agent (such as sucrose), adding 2-4 times of purified water (such as 3 times of purified water), and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, and sterilizing under hot pressure (such as 105 deg.C for 45 min).
According to the method of the second aspect of the invention, the Chinese medicinal composition is prepared from 1200 parts by weight of astragalus, 400-600 parts by weight of angelica, 300-500 parts by weight of prepared rehmannia root, 300-500 parts by weight of codonopsis pilosula, 100-300 parts by weight of donkey-hide gelatin, 20-40 parts by weight of ferrous gluconate and optional pharmaceutical excipients.
According to the method of the second aspect of the invention, the Chinese medicinal composition is prepared from 1200 parts by weight of astragalus, 400-600 parts by weight of angelica, 310-490 parts by weight of prepared rehmannia root, 300-500 parts by weight of codonopsis pilosula, 100-300 parts by weight of donkey-hide gelatin, 20-40 parts by weight of ferrous gluconate and optional pharmaceutical excipients.
According to the method of the second aspect of the invention, the Chinese medicinal composition is prepared from 1200 parts by weight of astragalus root, 450-550 parts by weight of angelica, 350-450 parts by weight of prepared rehmannia root, 350-450 parts by weight of codonopsis pilosula, 150-250 parts by weight of donkey-hide gelatin, 25-35 parts by weight of ferrous gluconate and optional pharmaceutical excipients.
According to the method of the second aspect of the present invention, the Chinese medicinal composition is prepared from 1200 parts by weight of astragalus root, 500 parts by weight of angelica, 400 parts by weight of prepared rehmannia root, 400 parts by weight of codonopsis pilosula, 200 parts by weight of donkey-hide gelatin, 32 parts by weight of ferrous gluconate and optionally pharmaceutical excipients.
According to the method of the second aspect of the present invention, the Chinese medicinal composition is a liquid preparation in the form of an oral liquid.
According to the method of the second aspect of the present invention, the Chinese medicinal composition is a liquid preparation in the form of oral liquid, and the amount of the prepared astragalus root is 8-16 g per 100 ml.
According to the method of the second aspect of the present invention, the Chinese medicinal composition is a liquid preparation in the form of oral liquid, and the amount of the prepared astragalus root is 10-14 g per 100 ml.
According to the method of the second aspect of the present invention, the Chinese medicinal composition is a liquid preparation in the form of oral liquid, which is prepared in an amount of 12g per 100ml of the astragalus root material used.
According to the method of the second aspect of the invention, the pharmaceutical excipient comprises a flavoring agent. In one embodiment, the flavoring agent is a sweetener, such as aspartame, acesulfame k, sodium saccharin, sucrose (e.g., white granulated sugar), and the like. The amount of these sweeteners can be easily determined according to the specific variety of the use and experience of those skilled in the art, for example, the amount of aspartame, acesulfame k, saccharin sodium and the like is usually 0.05% to 1%, especially 0.1%, for example, sucrose (e.g., white granulated sugar) can account for 5 to 25%, for example 10 to 20%, for example 10%, 12%, 15%, 20% of the weight of the Chinese medicinal composition of the present invention. In particular, the amount of sweetener to be used may be determined according to, for example, preferences of the individual user, and the choice of sweetener to be used is well known to those skilled in the art, and its type and amount do not affect the physicochemical properties of the product.
According to the method of the second aspect of the present invention, the pharmaceutical excipients further comprise sodium citrate and sorbitol. In one embodiment, the weight ratio of the medicinal materials astragalus root and sodium citrate is 12: 0.1. in one embodiment, the weight ratio of the medicinal materials astragalus and sorbitol is 12: 0.5. in one embodiment, sodium citrate and sorbitol are added to the filtrate obtained in step (2).
According to the method of the first aspect of the invention, the pharmaceutical excipients further comprise sodium tartrate and glycine. In one embodiment, the weight ratio of the medicinal materials astragalus root and sodium tartrate is 12: 0.25. in one embodiment, the weight ratio of the medicinal materials of astragalus and glycine is 12: 0.75. in one embodiment, sodium tartrate and glycine are added to the filtrate obtained in step (2).
Furthermore, the third aspect of the present invention provides a use of the traditional Chinese medicine composition according to any one of the embodiments of the first aspect of the present invention or the traditional Chinese medicine composition prepared by the method according to any one of the embodiments of the second aspect of the present invention in preparing a product for improving qi and blood functions of a human body, improving hypoxia tolerance, delaying senescence or inhibiting tumor cell growth, preventing and treating cancer.
Further, the present invention provides a method for determining the content of calycosin glucoside in the Chinese medicinal composition of any one of the first aspect of the present invention or the Chinese medicinal composition prepared by the method of any one of the second aspect of the present invention, using reversed phase high performance liquid chromatography using Kromasil C18 column (4.6 mm. times.200 mm, 5 μm), acetonitrile-water (28:72) as mobile phase, flow rate of 1.0mL/min, and detection wavelength of 267 nm.
According to any aspect of the invention, the traditional Chinese medicine composition can be used as a health product, a health food, a health drink or a medical product.
According to any aspect of the invention, the traditional Chinese medicine composition can be used as a health product, a health food, a health drink or a medical product.
Any embodiment according to any aspect of the invention, wherein the traditional Chinese medicine composition has a formulation as described in any one of the embodiments of the invention.
According to any of the embodiments of any of the aspects of the invention, wherein the Chinese medicinal composition has the formula and the preparation method as described in any of the embodiments of the invention.
In the above-described steps of the preparation method of the present invention, although the specific steps described therein are distinguished in some detail or in language description from the steps described in the preparation examples of the detailed embodiments below, those skilled in the art can fully summarize the above-described method steps in light of the detailed disclosure throughout the present disclosure.
Any embodiment of any aspect of the invention may be combined with other embodiments, as long as they do not contradict. Furthermore, in any embodiment of any aspect of the invention, any feature may be applicable to that feature in other embodiments, so long as they do not contradict. The invention is further described below.
All documents cited herein are incorporated by reference in their entirety and to the extent such documents do not conform to the meaning of the present invention, the present invention shall control. Further, the various terms and phrases used herein have the ordinary meaning as is known to those skilled in the art, and even though such terms and phrases are intended to be described or explained in greater detail herein, reference is made to the term and phrase as being inconsistent with the known meaning and meaning as is accorded to such meaning throughout this disclosure.
The traditional Chinese medicine composition is prepared from astragalus membranaceus, angelica sinensis, prepared rehmannia root, codonopsis pilosula, donkey-hide gelatin and ferrous gluconate.
Astragalus membranaceus (Fisch.) Bunge) is also called Astragalus membranaceus. The main root is thick, woody, branched and grey-white. The stem is upright, the upper part is multi-branched, and the stem has fine edges and is white and soft. Perennial herbs with a height of 50-100 cm. Produced in inner Mongolia, Shanxi, Gansu, Heilongjiang and other places, and is a national third-level protective plant. The astragalus root has been used for more than 2000 years, and has the functions of enhancing the immunologic function of organisms, protecting the liver, promoting urination, resisting aging, resisting stress, reducing blood pressure and having wider antibacterial action. But excessive superficial pathogenic factors, qi stagnation and dampness obstruction, food stagnation, excessive heat-toxicity at the early stage of superficial infection or after ulceration, and yin deficiency and yang hyperactivity are prohibited. Due to the long-term mass mining, the number of wild astragalus roots is sharply reduced in recent years, and the danger of extinction is prone to exist. Therefore, the plant is determined to be a gradually dangerous species, and the national third-level protection plant.
Huang Qi is sweet in nature and warm in taste, and enters lung, spleen, liver and kidney meridians.
The medicinal value of astragalus includes: 1. spontaneous sweating due to exterior deficiency: it is usually indicated for spontaneous sweating due to weak body and exterior. For example, Huang Qi combined with Bai Zhu and Fang Feng should be used for sweating due to insecurity of exterior qi, and it is effective after long-term administration. As for jade screen powder; it can also be combined with light wheat and radix Ephedrae. 2. Night sweat due to yin deficiency: it is combined with yin-nourishing herbs such as Sheng Di and Mai Dong, etc. 3. Edema due to acute nephritis: it is indicated for edema of deficiency type due to insufficiency of yang qi, and often combined with Fangji, Fu Ling and Bai Zhu, for instance, Fang Ji Huang Tang. 4. Edema due to chronic nephritis, deficiency of spleen and kidney: it is often combined with Dang Shen, Bai Zhu and Fu Ling. 5. Deficiency of yang-qi: it can be used for treating sore and ulcer without rupture and invagination, and has effects of promoting rupture and limiting. For long-time abscess and deep-rooted carbuncle without penetrating head, it is often combined with pangolin scales, Chinese honeylocust spine, Dang Gui and Chuan Xiong. 6. Ulceration of sores: for long-term unhealing, it is usually combined with Yin Hua, Zao Ci and Di Ding, etc., to promote tissue regeneration and heal up. For pus cleansing, it is combined with Dang Shen and Rou Gui. 7. Lung qi deficiency syndrome: cough and dyspnea with a long time, shortness of breath, mental fatigue, phlegm obstructing in the lung and failing to expectorate. It is combined with herbs of warming lung and relieving asthma and strengthening lung qi, such as Zi Wan and Fang Dong, etc. Spleen producing phlegm and lung storing phlegm, so it is good at strengthening taiyin to dispel phlegm, and Huang Qi is good at tonifying qi to treat qi deficiency. 8. Deficiency of vital energy: lassitude, hypodynamia, or sinking of the middle-warmer, rectocele, and prolapse of uterus. For tonifying qi and strengthening spleen, it is often combined with Dang Shen and Bai Zhu; for qi-tonifying and yang-raising with sinking of qi, it is often combined with Dang Shen, Sheng Ma, chai Hu and gan Cao-Zhi.
The preparation is clinically applied to: 1. hypertension; 2. ischemic heart disease; 3. acute glomerulonephritis; 4. positive gastric ulcer of helicobacter pylori; 5. psoriasis; 6. diabetes mellitus; 7. chronic rhinitis; 8. osteoporosis.
Astragalus membranaceus is a pure natural product which is frequently eaten by people, and smooth running of 'frequently drinking astragalus soup, preventing diseases and keeping health' is carried out in folk, which means that astragalus membranaceus and Qiongzhen lucid ganoderma are frequently used for decocting or soaking in water to replace tea for drinking, and the astragalus membranaceus has good disease prevention and health care effects. Radix astragali and ginseng both belong to good qi-tonifying drugs, and ginseng is mainly used for tonifying primordial qi and restoring yang from collapse, and is commonly used for treating acute diseases such as collapse, shock and the like with good effect. While Huang Qi is mainly tonifying deficiency, it is commonly indicated for chronic weakness, low speech and weak pulse. Some people are easy to catch cold when they meet weather change, the traditional Chinese medicine is called as 'exterior insecurity', astragalus can be used for strengthening exterior, and frequent taking of astragalus can avoid frequent cold.
Modern medical research shows that astragalus has the functions of enhancing the immunity of organisms, protecting the liver, promoting urination, resisting aging, resisting stress, reducing blood pressure and resisting a wide range of bacteria. Can eliminate albuminuria caused by experimental nephritis, enhance myocardial contraction force, and regulate blood sugar content. Radix astragali can not only dilate coronary artery, improve myocardial blood supply, and enhance immunity, but also delay cell aging process. The astragalus root is convenient to eat and can be used for decocting soup, decocting paste, soaking wine, adding into dishes and the like.
Astragalus root has the functions of invigorating qi, promoting the production of body fluid, and promoting the production of blood, and can mutually enhance the curative effect when being reinforced mutually. However, ginseng has strong action, is known as the first important herb for tonifying qi, and has the effects of tonifying qi, relieving collapse, soothing the nerves, improving intelligence, tonifying qi and supporting yang. Dang Shen is mild in action of tonifying qi, so it is specially indicated for tonifying qi of spleen and lung, and tonifying blood. Huang Qi is weaker than ren Shen in tonifying original qi, but it is good at tonifying qi and raising yang, tonifying defensive qi and consolidating superficial resistance, promoting tissue regeneration, inducing diuresis and alleviating edema, especially indicated for spleen deficiency and qi sinking and exterior deficiency with spontaneous sweating.
The chemical components of astragalus root mainly contain glycosides, polysaccharides, flavones, amino acids, trace elements, etc.
Prepared rehmannia root, original name: rehmannia, also known as: radix rehmanniae and radix rehmanniae Preparata. Latin name: rehmannia glutinosa (Gaetn.) libosh.ex fisch.et mey. scrophulariaceae, Rehmannia, dense-covered white, multicellular, long, velvety and glandular hairs. The rhizome is used as a medicine. The prepared rehmannia root, a traditional Chinese medicine, is a processed product of rehmannia root, has black and glossy surface, soft and flexible quality, sweet taste and mild nature, and has the effects of nourishing yin and supplementing blood, replenishing vital essence and replenishing marrow and the like. Can be used for treating deficiency of liver-yin and kidney-yin, soreness of waist and knees, hectic fever, night sweat, nocturnal emission, internal heat, diabetes, blood deficiency, sallow complexion, cardiopalmus, menoxenia, giddiness, tinnitus, and premature gray hair. The dried rehmannia root is prepared rehmannia root which is fumigated to be black and moist, is irregular block-shaped and has different sizes, the inside and the outside are painted black, and the product has luster and the outer surface is wrinkled and uneven. Has moist cross section, bright grease-like block in the center, high viscosity, soft texture, slight smell, and sweet taste. It is better to have a big, soft and moist root tuber, and black and glossy interior and exterior through nine times of steaming and sun drying.
The nature, flavor and meridian tropism. Sweet in taste; and (4) temperature. Liver diseases entering; the kidney channel. The efficacy is mainly as follows: enriching blood and moistening; replenishing vital essence and marrow; for sallow complexion due to blood deficiency; dizziness and palpitation; menoxenia; collapse is not stopped; deficiency of liver-kidney yin; tidal fever and night sweats; spermatorrhea and impotence; infertility; menoxenia; metrorrhagia and metrostaxis and bleeding; soreness and weakness of waist and knees; tinnitus and deafness; dizziness and blurred vision; the beard and hair are early white; quenching thirst; constipation; dyspnea and tachypnea due to kidney deficiency.
Rehmannia has a wide range of pharmacological actions. The comparison of the pharmacological effects of rehmanniae radix Preparata and rehmanniae radix upon the intravascular thrombotic syndrome shows that: the crude radix rehmanniae Preparata of pig gallbladder shape produced in China can strongly inhibit hemorrhagic necrosis of liver and simple necrosis. The antithrombin effect of rehmanniae radix preparata is weak. The activation of the fibrinolytic system was studied by the activation of plasminogen using the fibrin plate method, and it was found that rehmanniae radix had the activation but rehmanniae radix did not. It is also reported that the hemostatic action of rehmannia root before and after charring is not enhanced. The hemostatic effect of the water decoction of rehmannia root, prepared rehmannia root, rehmannia root charcoal and prepared rehmannia root charcoal is analyzed, and the result has no significant difference. The experiment shows that: the Huaiqing prepared rehmannia root decoction can relieve the weight loss of hyperthyroidism type yin-deficiency rats after being infused with water, obviously reduces the water intake and urine volume in 24 hours, obviously improves the concentration levels of T3 and T4 in blood plasma (namely, reduces T3 and increases T4) and obviously increases the level of AD (aldosterone in blood plasma). Proved that the medicine has stronger effect of nourishing yin. It is thought that the yin-nourishing and kidney-tonifying effects of rehmanniae radix Preparata are related to improving AD level in vivo.
The results of experiments show that the prepared rehmannia root decoction has obvious effects on the physiological activity of glutathione peroxidase (GSH-Px) in the blood serum of animals, the contents of lipid peroxide in the blood serum are reduced to a certain degree, but the activities of superoxide dismutase (SOD) in the blood are not statistically significant, the prepared rehmannia root has no effect on the protein metabolism of partial organs of rats, the prepared rehmannia root has a certain effect on inhibiting the mitosis of epithelial cells when orally taken, experiments show that the prepared rehmannia root decoction taking prepared rehmannia root as a main drug has the effect of reducing the weight, prolonging the swimming time and enhancing the physical strength of mice besides the weight, the phagocytic activity of the spleen lymph node and hair growth center of animals receiving chemical carcinogens is active, the phagocytic activity of the mononuclear macrophagic system can be enhanced in the initial stage of inoculating transplantation tumors, the proportion of albumin and globulin in the blood of the tumor-bearing animals can be increased similarly increased, the survival time of the tumor-bearing animals can be increased, the survival time of the mice is similar to the mice after the prepared by adding the prepared rehmannia root decoction of the prepared rehmannia root, the prepared according to the prepared rehmannia root, the prepared according to the prepared rehmannia root, the prepared according to the prepared rehmannia root, the prepared according to the prepared rehmannia root, the prepared according to the prepared rehmannia root, the prepared according to the prepared according to the.
In the aspect of Chinese medicine, Chinese angelica is regarded as the essential herb for blood because it has sweet and heavy flavor, and can tonify blood, and has light and pungent qi. Therefore, it can tonify blood, activate blood, dredge channels and activate collaterals. Radix Angelicae sinensis can be used for treating menoxenia, dysmenorrhea, blood deficiency, amenorrhea, sallow complexion, asthenia anemia, metrorrhagia, puerperal blood stasis, menorrhea (bleeding of mouth and nose during menstruation). The angelica is the most common medicine in the traditional Chinese medicine and is mostly used for cooking soup, and is particularly best for anemia patients. Can also remarkably promote the hematopoietic function of the organism and increase the content of red blood cells, white blood cells and hemoglobin. In terms of enriching and nourishing blood, angelica is sweet and heavy in flavor, so it is the first herb for enriching blood and indicated for pale or sallow complexion, lassitude, hypodynamia, pale and lusterless lips and nails, dizziness, palpitation and insomnia due to heart-liver blood deficiency. The Chinese angelica is combined with prepared rhizome of rehmannia, white peony root and Szechuan lovage rhizome to form a representative blood-enriching prescription, namely 'Siwu decoction', which has the functions of regulating menstruation and enriching blood and is particularly suitable for regulating and treating postpartum blood deficiency. In the aspect of relaxing bowel, traditional Chinese medicine considers that essence and blood are homologous, the body fluid of blood-deficient patients is insufficient, and constipation is easily caused by intestinal fluid deficiency. Dang Gui can moisten intestines to relieve constipation, and is often combined with Ma ren, Ku xing ren and Da Huang to treat constipation due to blood deficiency; the medicine can be combined with radix Saposhnikoviae, rhizoma Ligustici Chuanxiong, radix Paeoniae, radix et rhizoma Rhei, folium Menthae, herba Ephedrae, etc. to make into FANGFENGTONGSHENG powder with effects of clearing heat and relaxing bowels. In the aspect of regulating menstruation and activating blood, the angelica sinensis is light and pungent in qi, so the angelica sinensis can move blood, can clear and regulate the channels, activate collaterals and relieve pain, is particularly suitable for women, is particularly suitable for diseases such as irregular menstruation, dysmenorrheal, blood deficiency amenorrhea and the like, and is called as gynecological eriodictyon by ancient people. It is combined with peach kernel, safflower, prepared rehmannia root, white peony root and ligusticum wallichii to form a famous gynecological formula-Taohong Siwu Tang which is commonly used for premenstrual and dysmenorrhea. In the aspect of the effect on uterine smooth muscle, the angelica volatile oil has the inhibition effect on isolated uterus, enables rhythmic contraction to be in a relaxation state and resists uterine contraction. In the aspect of anticancer effect, Dang Gui can be widely used for various tumors, especially gynecological tumors, and is most suitable for stagnation of qi and blood and accumulation of blood stasis. For middle and late stage cancer with blood deficiency and emaciation or patients with deficiency of vital qi after operation, radiotherapy and chemotherapy, radix Angelicae sinensis can also be selected to strengthen body resistance and resist cancer. In the aspect of anti-aging, the angelica decoction has obvious influence on the learning and memory of mice, and the angelica can improve dementia caused by aluminum trichloride, reduce the peroxidized ester level of the brain of a dementia mouse and the oxidation activity of B-type monoamine and treat senile dementia by using Y maze method. In the aspect of preventing and treating chilblain, the traditional Chinese medicine thinks that although the chilblain is on the skin, the chilblain is mainly caused by insufficiency of yang qi of a body, invasion of exogenous cold, failure of yang qi to stretch and congealing cold and blood stasis. Therefore, it is usually treated by warming channel to dispel cold, promoting blood circulation to remove blood stasis, and relieving swelling and pain. Angelica sinensis, ginger and mutton soup is from treatise on miscellaneous diseases due to exogenous pathogenic factors. In the formula, the angelica has the effects of nourishing blood and activating blood, the ginger has the effects of warming yang and dispelling cold, and the mutton has the effects of tonifying deficiency and generating blood. In the aspect of immune function, the angelica sinensis and the sodium ferulate and the angelica sinensis polysaccharide which are extracted from the angelica sinensis have obvious stimulation effect on a mononuclear-macrophage system and have immune regulation and recovery effect on organisms with low immune function. Angelica sinensis can also promote lymphocyte transformation of healthy people. Dang Gui is good but contraindicated in Dang Gui, which should be taken carefully. Many people can eat angelica sinensis, but proper amount of the angelica sinensis needs to be taken, and if the angelica sinensis needs to be taken, side effects are easy to generate. Excessive oral administration of the angelica decoction and the powder can be disappeared after the medicine is stopped, if the powder is occasionally reacted with fatigue, somnolence and the like. The angelica volatile oil can be injected into acupoints to relieve fever, headache, dry mouth, nausea, etc. The blood pressure is reduced when a large dose is administered, and the blood pressure is suddenly reduced when the dose is increased, so that the breathing is stopped. The angelica ether extract has strong toxicity, and a small amount of the angelica ether extract can cause death. The clinical use of Dang Gui should not be excessive, and should be noticed after taking medicine for adverse reaction. Therefore, it is preferable to take the medicine as prescribed.
Dang Gui has various pharmacological actions. (1) The Chinese angelica aqua has the function of resisting thrombosis, and the Chinese angelica aqua has obvious inhibiting effect on the formation of artery and vein bypass thrombosis of rats by intravenous injection or oral administration. (2) Improving blood circulation, and increasing the diameter and blood flow velocity of pia mater arteriole after Middle Cerebral Artery Occlusion (MCAO) operation by butyl phthalide in radix Angelicae sinensis, thereby improving pia mater microcirculation. The apoptosis of neurons exists in the cerebral ischemia process, and the butylphthalide can weaken or stop the low-sugar hypoxia-induced apoptosis process of nerve cells and prevent the cerebral infarction area from expanding. (3) The radix Angelicae sinensis decoction or fluid extract has effect in inhibiting isolated Bufo siccus heart, and stopping heartbeat in diastole when dosage is large. The angelica has a protective effect on arrhythmia of myocardial ischemia reperfusion of rats, and 0.6g/kg of angelica injection is used for intraperitoneal injection of rats, so that the incidence rate of premature beat and the total incidence rate of arrhythmia are obviously reduced. (4) Improving coronary circulation, and intravenous injection of radix Angelicae sinensis decoction (2g/kg) can significantly increase coronary flow, reduce coronary resistance and myocardial oxygen consumption, increase cardiac output and cardiac index, and relieve myocardial infarction when blocking coronary artery. (5) Has effects in dilating blood vessel and relieving spasm due to Noradrenaline (NA). The angelica volatile oil is the main active part of angelica playing a role in relieving spasm of vascular smooth muscle, wherein ligustilide has the strongest activity. The angelica volatile oil also has strong inhibition effect on intestinal smooth muscle spasm. (6) The angelica has obvious inhibition effects on acute capillary permeability increase, tissue edema and chronic injury caused by various inflammatory agents, can inhibit granulation tissue proliferation in the later stage of inflammation, does not influence the weight of adrenal gland and thymus, and suggests that the anti-inflammatory effect of the angelica is independent of a pituitary-adrenal system. The water extract of angelica shows analgesic effect on writhing reaction caused by intraperitoneal injection of acetic acid, and the analgesic effect strength is 1.7 times of that of sodium acetylsalicylate. (7) The Chinese angelica powder (1.5g/kg) is orally taken, has the function of reducing the blood sugar of experimental hyperglycemia of rats and rabbits, and is realized by promoting the secretion of insulin. (8) Has lung protecting effect, and radix Angelicae sinensis can dilate pulmonary artery of rat, and reduce acute hypoxic pulmonary hypertension. The angelica has a certain blood pressure reducing effect on pulmonary hypertension of chronic obstructive pulmonary disease. (9) The angelica can increase the weight of solid matters in the bile and the discharge amount of cholic acid, and protect the activities of ATP enzyme, glucose-6-phosphatase and 5-nucleotidase, which indicates that the angelica has certain functions of protecting liver cells and restoring certain functions of the liver. (10) The angelica has certain protection effect on the kidney, can improve the glomerular filtration function and the renal tubule reabsorption function of rabbits after renal ischemia, relieves renal damage and promotes the recovery of renal tubule lesions. (11) Blood enriching effect, the angelica polysaccharide can activate macrophages, lymphocytes and the like in a hematopoietic microenvironment through direct and/or indirect ways, and can also stimulate muscle tissues to generate hematopoietic regulatory factors, further promote the proliferation and differentiation of functional hematopoietic stem cell granulocyte macrophage colony forming unit (CFU-GM) and stimulate myelogranulocytic monophylesis. In addition, angelica also exhibits the following effects: has effects in treating uterine smooth muscle, cardiovascular system, blood system, inflammation, nervous system, and asthma. In addition, in the aspect of clinical application, the angelica can treat muscle and joint pain and neuralgia, chronic tracheitis, chronic pelvic inflammatory disease, menstrual disease, hypertension, herpes zoster and rhinitis.
Codonopsis pilosula (scientific name; Codonopsis pilosula (Franch.) Nannf.) of Campanulaceae, perennial herb. The main effect of dangshen is to tonify qi. It is most suitable for treating listlessness, asthenia, and lassitude. Low voice, short subjective breathing, and dyspnea with short breath. For those with the emphasis on qi deficiency of spleen and stomach, there are general weakness, poor appetite, and loose stool, Dang Shen should also be used. Radix Codonopsis is usually combined with Atractylodis rhizoma, Poria and radix Glycyrrhizae Preparata, which is named formula Sijunzi decoction for invigorating qi and spleen. For both lung qi and spleen qi deficiency, it is also indicated to use Dang Shen in combination with Huang Qi, Bai Zhu, Fu Ling, Chen Pi, Dang Gui, Sheng Ma, chai Hu, gan Cao, Sheng Jiang and Zi Zao, which is a famous decoction for tonifying middle-jiao and Qi.
Dangshen has the great characteristics of benefiting qi and nourishing blood. So that the patients have deficiency of both qi and blood, shortness of breath, palpitation, fatigue, hypodynamia and pale complexion,radix Codonopsis is also suitable for people with dizziness, poor appetite, loose and soft stool, and common cold. Experiments prove that the codonopsis pilosula can increase red blood cells and red bloodEggThe white blood is increased, so the codonopsis pilosula is beneficial for anemia patients to eat. The radix Codonopsis has effect in promoting leukocyte increase due to leukocyte decrease caused by chemotherapy and radiotherapy. In recent years, it has been found that the combination of dangshen, astragalus and atractylodes can reduce the urine protein of chronic nephritis patients.
The actions of Dang Shen include many aspects. Specifically, (1) influence on blood cells: alcohol and water extract of radix Codonopsis can be administered orally or subcutaneously to increase red blood cells and hemoglobin of normal rabbit slightly; since the action is remarkably weakened after the removal of the spleen, it is presumed that the blood-replenishing action is related to the spleen, and at this time, the leukocyte tends to be reduced. Radix codonopsis immersion liquid 1: 40 has no hemolysis in the test tube, but can change color after reacting with erythrocyte, and generates turbidity and precipitation. (2) Effects on blood glucose: the codonopsis pilosula extract is injected subcutaneously on the abdomen of the rabbit, so that the blood sugar can be increased; however, if the fermented extract is injected or administered by gastric lavage, the effect is not good, so the blood sugar is considered to be increased because the root contains a large amount of sugar; it also does not inhibit the development of neurogenic hyperglycemia that occurs from diuretic injections. According to preliminary experiments, the radix codonopsis pilosulae can increase blood sugar by intragastric administration. (3) The function of reducing blood pressure: the injection of alcohol and water extract is intravenous or intraperitoneal, which can reduce the blood pressure of the anaesthetized dog, and according to the preliminary analysis, the injection is considered to be peripheral; and has some anti-adrenergic effects; the water extract or alcohol or water extract can also reduce blood pressure of anesthetized animals, and inhibit isolated toad heart. For chronic hypertension dogs, 4g (crude drugs)/kg of the water extract is infused every day, and the blood pressure reducing effect is not seen. The extract or total glycoside of root of plants of the same genus can increase erythrocyte application (17.5%) and increase body weight (23%) when feeding rabbits for a long time (40 days); has effects of preventing and treating leukocytosis caused by turpentine; after long-term oral administration, no pathological changes are found in the internal organs. (4) Effects on the center: the radix Codonopsis decoction can be used for resisting convulsion of mice caused by Nitrosostenin, prolonging convulsion occurrence time, prolonging survival time of mice, and resisting electroconvulsive. The radix Codonopsis decoction can remarkably resist mouse memory disorder caused by scopolamine; it also has effect in resisting memory reproduction disorder of mice caused by ethanol. (5) Effect on cardiovascular system: the ethanol extract and water extract have blood pressure lowering effect due to peripheral vasodilatation, and the ethanol extract has effect in inhibiting isolated Bufo siccus heart. (6) Effect on blood: the codonopsis pilosula water-soluble substance is used for gastric lavage, and has an inhibitory effect on platelet aggregation of rats induced by ADP. The radix Codonopsis product can significantly increase red blood cells and significantly reduce white blood cells of rabbits. (7) Antiulcer effect: radix Codonopsis has effects in resisting gastric mucosa injury and enhancing gastric mucosa cell protection. (8) Impact on immune function: the codonopsis pilosula decoction can obviously promote the biosynthesis of DNA and protein of spleen lymphocytes activated by ConA and has obvious enhancement effect on the generation of leukocyte mediator-2 (IL-2). It also has effect in enhancing phagocytic function of mouse reticuloendothelial system. (9) Fatigue resistance and anti-hypoxia effect: the codonopsis pilosula decoction can prolong the weight swimming time of the mice; and can significantly prolong the survival time of the hypoxic mouse.
Colla Corii Asini has effects of replenishing blood, stopping bleeding, nourishing yin, and moistening dryness. It is mainly indicated for syndrome of blood deficiency, consumptive disease hemoptysis, hematemesis, hematuria, hematochezia, bloody dysentery, pregnancy bleeding, metrorrhagia and metrostaxis, yin deficiency, vexation, insomnia, cough due to lung deficiency, and convulsion due to stirring of deficient wind. There are many aspects to the action of E-jiao. For example, (1) effects on the hematopoietic system: the donkey-hide gelatin has strong blood-enriching function and the curative effect is better than that of iron preparation. (2) Anti-shock effect: can restore the blood pressure of extremely low level to normal level and has long-lasting effect. (3) Effect on progressive nutritional myodegeneration: in guinea pig trials, human-like, nutritional progressive myodegeneration may occur. (4) Effects on calcium metabolism: has positive calcium balance effect, and is also beneficial to patients with muscle degeneration. The traditional Chinese medicine mainly uses the donkey-hide gelatin to treat diseases caused by blood deficiency clinically. With the improvement of the life quality of people, more and more people use the donkey-hide gelatin to build up the body and maintain beauty and keep young. (1) Treating blood diseases: the donkey-hide gelatin-containing Chinese patent medicine for treating anemia has obvious effects of treating iron deficiency anemia, aplastic anemia, thrombocytopenia, leukopenia and the like, and contains the following donkey-hide gelatin: donkey-hide gelatin blood-enriching oral liquid, Shandong donkey-hide gelatin paste, compound donkey-hide gelatin liquid, angelica blood-nourishing pills and the like. (2) And (3) fetus protection and fetus protection: colla Corii Asini can also be used for threatened abortion, and habitual abortion in gestation period. (3) Menstruation disease: donkey-hide gelatin has the main actions of nourishing yin and blood, removing blood stasis and stopping bleeding. For menstrual diseases and blood deficiency, E jiao can be used for tonifying, blood excess can be used for consolidating and controlling, and blood deficiency can be used for promoting blood circulation. (4) Bleeding: through compatibility, colla Corii Asini can be used for the treatment of various hemorrhagic diseases, such as hematemesis, hematochezia, hematuria, menorrhagia, metrorrhagia and metrostaxis and postpartum hemorrhage. (5) Preventing and treating senile diseases and delaying aging: the donkey-hide gelatin has the functions of nourishing blood, enriching blood and tonifying qi, and is used for treating various senile diseases such as climacteric syndrome, insomnia, sick sinus syndrome, hypotension, diabetes, rheumatoid arthritis, osteoporosis, senile dementia and the like. (6) And (3) cancer prevention and resistance: the expression is to improve the lymphocyte transformation rate of tumor patients, inhibit the growth of tumors, and reduce the toxicity of other anti-cancer drugs and chemotherapy, so that the treatment process can be successfully completed. The donkey-hide gelatin is commonly used in clinic in traditional Chinese medicine to be matched with other medicines for treating leukemia, nasopharyngeal carcinoma, esophageal cancer, lung cancer, breast cancer and the like. (7) Strengthening physique and beautifying: the donkey-hide gelatin is not warm and dry, is suitable for both the old and the young, can be used all the year round, and is a good tonic product for building up the body. Until now, in many families in Shanghai, Jiangsu and Zhejiang, donkey-hide gelatin is used in winter and then is matched with rock sugar, walnut kernel, black sesame, longan, Chinese date and the like to prepare thick paste which is taken with warm boiled water in the morning and evening, and people feel strong strength, enhanced cold resistance and less cold after the thick paste is taken. The donkey-hide gelatin is taken by pregnant women before and after delivery, which is beneficial to the growth of children and the recovery of the body after delivery. The donkey-hide gelatin is rich in protein degradation components, has the effect of moistening the skin by enriching the blood, is beneficial to the health care of the skin, can make the face ruddy, tender, glossy and good in elasticity after being used, has certain effect of removing speckles, and is also used for protecting and nourishing the skin. The donkey-hide gelatin is widely applied to Chinese medicine formulas and folks, and is also widely applied to the production of Chinese patent medicines. 181 of the Chinese patent medicines approved by the state in 2000 contain donkey-hide gelatin.
The molecular formula of the ferrous gluconate is C12H22O14Fe & 2H2O, and the relative molecular mass is 482.18. Can be used as color fixative and nutrition enhancer in food, and is prepared by neutralizing gluconic acid with reduced iron. The ferrous gluconate has the characteristics of high bioavailability, good solubility in water, flat flavor and no astringent taste, and is more strengthened in milk beverages. Ferrous gluconate is an excellent iron supplement, has high ferrous absorption rate, is immediately oxidized into ferric ions after entering blood, is combined with transferrin in blood plasma to form plasma iron, is transported to tissues such as liver, spleen, bone and the like by taking the transferrin as a carrier, and is stored in a ferritin form, iron of the ferritin in the bone can be combined into hemoglobin, and the hemoglobin is formed in skeletal muscle, so that the plasma iron transport rate is increased and the absorption rate is accelerated when iron is deficient, and the iron absorption amount is increased. Ferrous gluconate is excreted mainly through the intestine and skin, and a small amount through bile and sweat. Ferrous gluconate, like ferrous sulfate, participates in the synthesis of hemoglobin and plays an important role in oxygen transfer and metabolic activities of the human body. The ferrous gluconate is mainly used for treating iron deficiency anemia caused by chronic blood loss, menorrhagia, pregnant women, lactating women and children in development period.
The product formula of the invention comprehensively utilizes two types of components to achieve better effect; the product is an oral liquid preparation, has the advantages of quick absorption, quick effect, convenient use, stable quality, easy carrying, easy storage, more accurate dosage and the like, and is certainly popular with people. Therefore, the Hairikang Xueerhong oral liquid is researched and developed to meet the market demand, and has wide market prospect and far-reaching social benefit.
Anemia is a blood disease which is commonly expressed by the reduction of the total amount of cells or hemoglobin of the whole body, so that the oxygen carrying function of blood is insufficient, and the traditional Chinese medicine considers that: the generation of blood is closely related to the spleen, so "the middle energizer receives qi and takes juice to indicate blood" in the "Nei Jing" (internal classic of medicine); ling Shu (Ling Shu) refers to the treatment of deficiency of spleen and stomach, which is commonly called blood disease; the spleen-rib theory discusses that when the spleen and stomach are weakened and the function is disordered, the food is not stored enough, and the essence is deficient or the absorption and utilization of the essence are disturbed, which affects the generation of blood. Nutritional anemia is caused by malnutrition and hematopoietic disorder, and iron deficiency anemia belongs to the nutritional anemia. The primary disease is treated actively, excessive blood loss is prevented, and the disease is treated by killing insects and supplementing iron in western medicine clinically; in traditional Chinese medicine, the basic principle of benefiting qi and generating blood is adopted to synthesize symptoms, namely syndrome differentiation plus-minus, and methods of tonifying liver and kidney, warming and invigorating spleen and kidney, invigorating spleen and supplementing qi, tonifying qi and nourishing yin and the like are applied. The formula is based on the Chinese medicine theory, refers to the empirical prescription for improving anemia at all times, combines the latest progress of modern medicine research, and is prepared according to the principle of Chinese medicine theory group. The Hairikang Xueerhong oral liquid is based on the action mechanism, and aims to supplement nutrient substances necessary for hematopoiesis of human bodies and prevent the hypohematopoiesis caused by insufficient formation of hemoglobin or generation of red blood cells. The formula is the astragalus root which can greatly tonify qi of spleen and fu organs and can be used as a source for qi and blood generation; chinese angelica, sweet and pungent with warm property, nourishes blood and nourishes ying, promotes yang and yin, and promotes qi and blood; colla Corii Asini, radix rehmanniae Preparata with effects of nourishing yin and blood, and radix Codonopsis with effects of invigorating qi and nourishing blood; ferrous gluconate for preventing iron deficiency anemia.
In the formula of the composition, the astragalus has the functions of improving cardiovascular and cerebrovascular vessels, relieving the accumulation of calcium in myocardial cells, myocardial tissues and erythrocytes caused by ischemia, and protecting the calcium pump function of the erythrocytes, thereby relieving the change of the myocardial ultrastructure caused by ischemia and hypoxia. Angelica sinensis can increase the number of peripheral red blood cells, white blood cells, hemoglobin and bone marrow nucleated cells. Radix rehmanniae Preparata has effects of enhancing immunity, delaying aging, resisting tumor, tranquilizing mind, resisting radiation, resisting oxidation, affecting protein metabolism, glucocorticoid and blood sugar. Radix Codonopsis has effects of resisting oxidation, promoting increase of acetylcholine, improving memory, promoting erythropoiesis, dilating capillary vessel, and increasing blood flow. The donkey-hide gelatin has certain effect on the hematopoietic function of bone marrow, can quickly recover hemoglobin and red blood cells of hemorrhagic anemia, and has strong blood enriching effect. Ferrous gluconate has the functions of synthesizing hemoglobin, synthesizing myoglobin, synthesizing stored iron and the like; are essential components for constituting various metalloenzymes or activating certain metalloenzymes and its cofactors.
One of the most fundamental hazards of anemia to health is that the oxygen carrying capacity is low, which affects the exertion of various system functions of the whole body, resulting in a series of common symptoms and physical signs affecting the life and quality of life of people. The composition uses the donkey-hide gelatin and the prepared rehmannia root as the medicines, is sweet, warm, thick in taste, soft and moist in quality, is good at nourishing yin and blood, angelica sinensis is capable of enriching the blood and nourishing the liver, regulating blood and regulating menstruation, blood is a tangible substance, and the qi belongs to an intangible purpose, and the blood circulation depends on the qi, so that the codonopsis pilosula and the astragalus root are used for greatly tonifying the qi of spleen and lung to enrich the source of qi and blood generation. Ferrous gluconate is used as iron supplement. It is indicated for nutritional anemia. The health-care tea has a unique formula, is safe and nontoxic, has a definite health-care function and has a wide development prospect. The composition has the advantages of easily available raw materials, reasonable process, low production cost, reasonable dosage form and convenient carrying, and is suitable for middle-low income patients. Therefore, the product can be expected to have wide development prospect in the market, and will certainly generate great social benefit and good economic benefit.
In the formula of the traditional Chinese medicine composition, the astragalus membranaceus greatly tonifies qi of spleen and lung so as to provide a source for qi and blood generation; chinese angelica, sweet and pungent with warm property, nourishes blood and nourishes ying, promotes yang and yin, and promotes qi and blood; colla Corii Asini, radix rehmanniae Preparata with effects of nourishing yin and blood, and radix Codonopsis with effects of invigorating qi and replenishing blood; ferrous gluconate supplements iron. The efficacy is as follows: tonify qi and nourish blood, and nourish yin and nourish blood. The health care function is as follows: improving nutritional anemia. Radix astragali is dried root of Astragalus membranaceus bge or Astragalus membranaceus bge of Leguminosae. The radix astragali contains astragaloside, astragalus polysaccharides, choline, sucrose, flavone, amino acids, bitter principle, folic acid, flavan compound, selenium, silicon, zinc, cobalt, daucosterol, soybean saponin, etc. Nature and taste: sweet and slightly warm; spleen and lung meridian entered; the functions are as follows: invigorating qi, invigorating yang, tonifying wei-defensive qi, consolidating superficial resistance, expelling toxin, promoting granulation, inducing diuresis, and relieving swelling. Indications and application: astragalus root is the essential drug for invigorating qi, and raw astragalus root runs out of the exterior and is mainly used for strengthening the exterior, arresting sweating, expelling toxin and discharging pus; moxibustion is focused on invigorating qi, raising yang, inducing diuresis to alleviate edema. The root of Angelica sinensis (oliv.) Diels of Umbelliferae is used as the root of Angelica sinensis (oliv.) Diels. The angelica has been used as a medicine for a long time, and is listed as a traditional Chinese medicine capable of attacking and tonifying as early as Shen nong Ben Cao Jing, which can not only strengthen the body resistance and tonify the body resistance, but also attack pathogenic factors to treat diseases, and the primary effect of the angelica is to enrich the blood. The radix Angelicae sinensis contains ferulic acid, various amino acids, radix Angelicae sinensis polysaccharide, pyrimidine, purine, and vitamin B12Vitamin E, linoleic acid, succinic acid, nicotinic acid, etc., and contains trace elements such as manganese, zinc, etc., and volatile oil. Nature and taste: sweet, pungent and warm; heart, liver and spleen meridians entered; the functions are as follows: tonify blood, activate blood and regulate menstruation① is used for treating blood deficiency, ② is used for treating irregular menstruation, amenorrhea and dysmenorrheal, and is a key medicine for regulating menstruation in gynecology, radix rehmanniae preparata is root of perennial herb rehmannia glutinosa in Scrophulariaceae, radix rehmanniae preparata contains sitosterol, mannitol, a small amount of stigmasterol, lutein, catalpol, hexanoyl catalpol, daucosterol, digitonin, monoterpene and glycosides, and also contains organic acid, glucose, sucrose, fructose, raffinose, mannitol, galactose, vitamin A, various amino acids and various trace elements, wherein the sexual taste is sweet and mild temperature, the meridian tropism is liver and kidney meridian entered, the efficacy of nourishing blood and yin, replenishing essence and benefiting marrow, the main treatment and application is ① for treating blood deficiency, palpitation, insomnia, irregular menstruation, metrorrhagia, dizziness, the application is 3936 for treating kidney yin deficiency, heat, night sweat, tidal sperm, thirst, and other diseases, ③ for treating soreness of feet, tinnitus, early morning glory deficiency, deafness, tinnitus, white fungus, leukotrichia, platycodon root of radix codonopsis, platycodon, vitamin B, and other plant diseases1、B2The donkey-hide gelatin is prepared from donkey-hide gelatin, bone glue, nitrogen 16.43-16.54%, various proteins, amino acids, calcium, sulfur, lysine, arginine, histidine, etc., the root of the donkey-hide gelatin is prepared from donkey-hide gelatin, bone glue, nitrogen 16.43-16.54%, astragalus root, calcium, sulfur, etc., the lysine, arginine, histidine, etc., the licorice, the arginine, the angelica, the spleen-kidney, the spleen-stomach-nourishing medicine, the spleen-qi-tonifying medicine, the spleen-nourishing medicine, the spleen-stomach-nourishing medicine, the spleen-tonifying medicine③ ferrous gluconate is a nutrient enhancer with iron content of 11%, and iron in vivo is divided into two essential and non-essential parts according to its function, the essential part accounts for 70% of the total iron in vivo and exists in hemoglobin, myoglobin, heme enzymes, cofactors and transport iron, the non-essential part is iron reserve in vivo and exists in liver, spleen and bone marrow mainly in the form of ferritin and siderite, iron is an essential element with the most abundant content in human body, can synthesize hemoglobin, and is an essential component for constituting various metalloenzymes, can activate certain metalloenzymes and their cofactors to participate in the synthesis of hormones or enhance the action of hormones, has the functions of maintaining the normal immune function of the body, enhancing the bactericidal and phagocytic functions of neutrophils, and can reduce the total iron-deficiency of the whole body, sanitary tissue survey results, 10% of the blood deficiency of women, 40% of the blood in the blood metabolism of women, 40% of the blood deficiency, the iron-carrying proteins and the iron-carrying proteins in the blood metabolism of the whole body, the blood deficiency of the spleen and the spleen, the blood metabolism of the spleen, the blood deficiency of the spleen and the blood of the childrenBlood "; ling Shu (Ling Shu) refers to the treatment of deficiency of spleen and stomach, which is commonly called blood disease; the spleen-rib theory discusses that when the spleen and stomach are weakened and the function is disordered, the food is not stored enough, and the essence is deficient or the absorption and utilization of the essence are disturbed, which affects the generation of blood. Nutritional anemia is caused by malnutrition and hematopoietic disorder, and iron deficiency anemia belongs to the nutritional anemia. The primary disease is treated actively, excessive blood loss is prevented, and the disease is treated by killing insects and supplementing iron in western medicine clinically; in traditional Chinese medicine, the basic principle of benefiting qi and generating blood is adopted to synthesize symptoms, namely syndrome differentiation plus-minus, and methods of tonifying liver and kidney, warming and invigorating spleen and kidney, invigorating spleen and supplementing qi, tonifying qi and nourishing yin and the like are applied. The formula is based on the Chinese medicine theory, refers to the empirical prescription for improving anemia at all times, combines the latest progress of modern medicine research, and is prepared according to the principle of Chinese medicine theory group. The Hairikang Xueerhong oral liquid is based on the action mechanism, and aims to supplement nutrient substances necessary for hematopoiesis of human bodies and prevent the hypohematopoiesis caused by insufficient formation of hemoglobin or generation of red blood cells. The formula is the astragalus root which can greatly tonify qi of spleen and fu organs and can be used as a source for qi and blood generation; chinese angelica, sweet and pungent with warm property, nourishes blood and nourishes ying, promotes yang and yin, and promotes qi and blood; colla Corii Asini, radix rehmanniae Preparata with effects of nourishing yin and blood, and radix Codonopsis with effects of invigorating qi and nourishing blood; ferrous gluconate for preventing iron deficiency anemia.
Qi-blood deficiency refers to qi deficiency and blood deficiency in traditional Chinese medicine. The traditional Chinese medicine considers that 'qi' and 'blood' are basic substances for forming and maintaining life activities of human bodies, people are easy to sleep in spring just because of deficiency of qi and blood, and sleep can just nourish qi and blood, so people are more sleepy than other seasons. People with qi deficiency are prone to fatigue, cannot keep working and often have weakness in limbs. The traditional Chinese medicine has knowledge of deficiency of qi and blood: qi is a delicate substance that travels in the human body. Has strong energy activity to stimulate and promote the function of organs of the body, thus representing the qi of five zang organs and the qi of meridians. Qi plays a major role in warming the body and resisting the invasion of exogenous pathogens, and also participates in the metabolism of visceral functions. Blood is the red fluid flowing in the meridians. Blood functions in two ways. First, it is to nourish the zang-fu organs, body constituents, meridians and orifices. Blood exuberance can make the body healthy, the face ruddy, the skin smooth, the hair moist and the joints flexible. Secondly, blood is the material basis for mental activities. Exuberant blood can induce the mind to refresh qi and induce quick thinking. Blood deficiency is marked by absentmindedness, palpitation and uneasiness. The deficient qi and blood can cause the hypofunction of zang-fu organs, leading to premature senility. Qi deficiency means the hypofunction of the zang-fu organs and poor resistance to disease, manifested as aversion to cold, cold limbs, spontaneous perspiration, dizziness, tinnitus, listlessness, fatigue, weakness, palpitation, shortness of breath and hypoevolutism. Blood deficiency can lead to lusterless sallow complexion, dry skin, withered hair, dry nails, dim eyesight, numb hands and feet, insomnia, dreaminess, amnesia, palpitation and absentmindedness. Deficiency of both qi and blood pertains to both qi and blood disorders. Qi and blood deficiency can cause malnutrition of the body, with the common symptoms of lassitude, shortness of breath, laziness in speaking, pale or sallow complexion, dizziness, pale lips and nails, palpitation, insomnia, pale tongue and weak pulse. The common causes are: qi deficiency results in blood deficiency, and qi and blood deficiency due to long-term illness. Common symptoms are: aversion to cold, cold limbs, spontaneous perspiration, dizziness, tinnitus, fatigue, weakness, palpitation, etc. Qi and blood are the material basis for maintaining the normal functions of the body, and can promote blood circulation, and blood can transport carrier gas, so that qi and blood are bred, and qi deficiency results in blood deficiency and blood deficiency results in qi deficiency. The chronic disease impairs qi and blood, resulting in deficiency of both qi and blood. The clinical manifestations of deficiency of qi and blood are deficiency of qi and blood, weak constitution, aversion to cold, cold limbs, spontaneous sweating, dizziness, tinnitus, fatigue, weakness, palpitation, shortness of breath and hypoevolutism due to qi deficiency. Blood deficiency can lead to lusterless sallow complexion, dry skin, withered hair, dry nails, dim eyesight, numb hands and feet, insomnia, dreaminess, amnesia, palpitation and absentmindedness. Deficiency of qi and blood can lead to fatigue, shortness of breath, no desire to speak, pale or sallow complexion, dizziness, pale lips and nails, palpitation, insomnia, scanty menstruation, delayed or amenorrhea, pale tongue and weak pulse. The main syndrome of deficiency of both qi and blood: sallow complexion, shortness of breath, no speaking desire, lassitude, hypodynamia, dizziness, palpitation, poor sleep, poor appetite, pale tongue and soft and thready pulse. The deficiency of qi and blood can be judged from the following aspects: 1. eye: the color and clarity of the eyes, the white color of the eyes becomes turbid, yellow and bloody, indicating insufficiency of qi and blood. 2. Skin: the white and pink skin has luster, elasticity, no wrinkles and no spots, and represents the sufficiency of qi and blood of the lung. Rough skin, no luster, dark, yellow, white, bluish, red, and blotchy skin, indicating poor condition and deficiency of qi and blood. 3. Hair: the growth rate of hair is related to liver blood, if liver blood is insufficient, hair grows slowly, hair is dry and falls off, hair is yellow, white and split, which indicates that qi and blood are insufficient, and liver blood and kidney qi decline. 4. Gingiva: gingiva is associated with the stomach and intestine, and gingival atrophy represents a deficiency of qi and blood. 5. Nail: there is no semilune on the finger or semilune on the thumb, and longitudinal striation appears on the nail, indicating that the body is heavy in cold and qi, deficiency of both qi and blood, and overdraft appears, which is the sign of aging of the body. 6. Finger: the finger is full, and the flesh is elastic, indicating sufficient qi and blood; a flat, weak finger or thin finger tip indicates insufficient qi and blood. 7. Sleeping: the sleep is fast, the sleep is deep, the breathing is uniform, and the people can sleep to wake naturally, which indicates that the qi and blood are sufficient; difficulty in falling asleep, easy fright and easy wakening, profuse urine at night, deep and heavy breath or snore, which indicates deficiency of both qi and blood. 8. And (3) movement: the state of chest distress, short breath and fatigue difficult to recover during exercise indicates that the qi and blood are insufficient. 9. Temperature of the hand: hands are warm with sufficient qi and blood; if the palm is hot or sweaty or cold, it is the manifestation of deficiency of qi and blood. Briefly, deficiency of qi and blood means movement asthma and palpitation, while deficiency of blood means yellow complexion, whitish complexion, dizziness, palpitation and poor sleep.
The aging process is characterized by physiological aging and pathological aging, the former refers to physiological degeneration process after maturation, the latter refers to aging process caused by various external factors (including various diseases), the latter refers to physiological degeneration process of the human body, the physiological metabolism process of the human body, the aging process of the human body, the physiological metabolism process of the aging, the aging process of the human body, the aging process of the human body, the process of the aging process of the aging process of the.
The tumor cell parenchyma is a tumor. The tumor tissue is composed of parenchyma and stroma, and the tumor parenchyma is tumor cells, is a main component of the tumor and has tissue source specificity. It determines the biological characteristics of the tumor and the specificity of each tumor. The tissue origin of various tumors is generally identified according to the parenchymal morphology of the tumor, classification, naming and histological diagnosis of the tumor are performed, and the benign and malignant degree of the tumor and the malignant degree of the tumor are determined according to the differentiation maturity degree and the size of the heterogeneity. Tumor cells have three significant basic features: immobility, migration and loss of contact inhibition. In addition, tumor cells have many physiological, biochemical and morphological features that differ from normal cells.
Tumor refers to abnormal hyperplasia caused by the gene change and loss of normal regulation and control of the growth of cells under the action of tumorigenic factors. Can be divided into two categories, benign and malignant tumors. The former has slow growth, clear boundary with surrounding tissues, no transfer and little harm to human health. The latter grows rapidly, can be transferred to other parts of the body, can also produce harmful substances, damage normal organ structures, cause organism dysfunction and threaten life. The tumor tissue is composed of parenchyma and stroma, and the tumor parenchyma is tumor cells, is a main component of the tumor and has tissue source specificity. The tumor stroma, which serves to support and nourish the tumor parenchyma, is not specific and generally consists of connective tissue and blood vessels, and sometimes lymphatic vessels.
Tumor cells have three significant basic features: immobility, migration and loss of contact inhibition. In addition, cancer cells have many physiological, biochemical and morphological features that are different from normal cells. Tumor cells are different in size and form, generally larger in size than the original cells, and high in growth speed, and have a nuclear-to-cytoplasmic ratio which is significantly higher than that of normal cells and can reach 1:1, the normal differentiated nucleus-to-cytoplasm ratio is only 1: 4-6. The cores have different shapes and can have the phenomena of megakaryokinesis, binuclear or multinuclear. The nuclear chromosomes are in an aneuploidy state (aneuploidy), some of the chromosomes are deleted, and some of the chromosomes are increased in number. Abnormal changes in normal cell chromosomes initiate the apoptotic process, but in cancer cells, apoptosis-related signaling pathways become dysfunctional, i.e., cancer cells are immortal. Mitochondria exhibit different polytypes, swelling, hyperplasia, such as hypertrophic mitochondria in eosinophilic adenomas are tightly packed inside the cell, and giant mitochondria appear in hepatoma cells. Cytoskeletal disturbance, a decrease in certain components, abnormal assembly of the skeleton. Cell surface characteristics are altered, producing tumor associated antibodies (tumorassociatedigien).
Generally, various tumors, patients with body fluid impairment and yin robbery are mostly yin deficiency with internal heat, so pungent, warm and dry heat foods should be avoided in diet regulation, and less eating is recommended for greasy food; in the middle and late stages of cancer, deficiency syndrome and cold syndrome are the main symptoms, and foods such as warming and invigorating spleen and stomach, tonifying qi and generating blood are advocated on diet, while foods with cold and cool nature should be eaten little or not. The diet contraindication of cancer patients is different in different disease categories, for example, patients with nasopharyngeal carcinoma should avoid pungent, warm, dry and hot, fried and roasted food, dog meat, mutton, pepper, fennel, etc. during the radiotherapy period; patients with gastric cancer are prohibited from eating pungent and dry food, cassia bark, mustard, pepper and the like; old pork and old duck are forbidden for patients with esophageal cancer; mother pork and few leeks are forbidden for patients with liver cancer. In a word, proper diet should be avoided, and blindly avoiding diet will cause malnutrition and affect recovery from diseases. The life must be maintained by various nutrients in the food. The most important problem of cancer patients is nutrition disorder, and improving the nutrition of patients is the most important measure in anticancer treatment: (1) it can be used for protein food such as milk, fish, egg, and bean product, and has anticancer effect. Wherein the milk and egg can improve protein disorder after radiotherapy. (2) Proper amount of sugar is taken to supplement heat. When a patient is treated by a large dose of radiation, the sugar metabolism in the body of the patient is destroyed, the glycogen is rapidly reduced, and the lactic acid in the blood is increased and can not be reused; and insulin insufficiency worsens. Therefore, the effect of supplementing glucose is better, and in addition, honey, rice, flour, potatoes and other foods with rich sugar are more suitable to be eaten to supplement heat. (3) More foods with anticancer effect, such as Amyda sinensis, Agaricus campestris, Auricularia, Bulbus Allii, Sargassum, and caulis et folium Brassicae Junceae, etc., can be eaten. (4) Patients with radiotherapy and chemotherapy should eat cold food and cold drink, but patients with cold feeling should eat hot food. (5) Researches show that cordycepin contained in the cordyceps sinensis can effectively phagocytize tumor cells, has the effect of 4 times of selenium, can enhance the capability of red blood cells to adhere to the tumor cells, and can play a role in preventing tumor recurrence and metastasis during tumor chemotherapy and after tumor surgery. (6) The food is diversified, and the color, the fragrance and the taste are noticed, so that the appetite of the patient is promoted; the cooking food is mostly cooked, boiled and stewed, and the food which is difficult to digest is contraindicated, and the drinking is forbidden. (7) Vitamins A and C have the effects of preventing cell degeneration and diffusion, and increasing epithelial cell stability, and vitamin C can also prevent common symptoms of radiation injury, and can increase leukocyte level; vitamin E can promote cell division and delay cell aging; vitamin B1 can stimulate appetite and relieve symptoms caused by radiotherapy. Therefore, foods rich in the above vitamins, such as fresh vegetables, fruits, sesame oil, cereals, beans, and animal viscera, should be eaten more.
The present inventors have found that the compositions of the present invention are useful for the prevention and treatment of cancer by inhibiting the growth of tumor cells. Specifically, 40ml of the composition obtained in example 215 of the present invention was administered to 31 benign tumor patients each day, twice a day in the morning and at night, and after half a year of administration, the composition of the present invention was significantly improved in qi and blood functions, significantly more vigorous in energy, and greatly improved in sleep, which may be associated with the inhibition of tumor cell growth, indicating that the composition of the present invention has an excellent effect of inhibiting tumor cell growth. The pharmacodynamic tests herein also demonstrate the above results.
The technical solution of the present invention has been proved to exhibit one or more unexpected advantageous effects by a number of experiments.
Detailed Description
The present invention will be further described by the following examples, however, the scope of the present invention is not limited to the following examples. It will be understood by those skilled in the art that various changes and modifications may be made to the invention without departing from the spirit and scope of the invention. The present invention has been described generally and/or specifically with respect to materials used in testing and testing methods. Although many materials and methods of operation are known in the art for the purpose of carrying out the invention, the invention is nevertheless described herein in as detail as possible.
In the following examples, when preparing the composition, if not specifically mentioned, the amount of astragalus per administration is not less than 1200g, the prepared oral liquid is finally packaged in glass bottles, 10ml per bottle; however, when the formulation is described below, it is expressed in terms of the amount of the Chinese medicinal composition to be administered per 100ml of the oral liquid to be prepared.
In the invention, the prepared traditional Chinese medicine composition in the form of oral liquid can be called Xueerhong oral liquid; or the oral liquid can be called as Hairikang brand oral liquid of astragalus, angelica and donkey-hide gelatin because the oral liquid comprises three important medicinal materials of astragalus, angelica and donkey-hide gelatin.
Example 1: preparation of traditional Chinese medicine composition of astragalus, angelica and donkey-hide gelatin oral liquid
The formula is as follows: 12g of astragalus, 5g of angelica, 4g of prepared rehmannia root, 4g of codonopsis pilosula, 2g of donkey-hide gelatin, 0.32g of ferrous gluconate, 12g of white granulated sugar and a proper amount of purified water are prepared into 100 mL.
The preparation method comprises the following steps:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata, and radix Codonopsis with purified water twice (6 times of purified water for 2 hr for the first time, filtering to obtain filtrate, decocting the residue with 6 times of purified water for 2 hr for the second time, filtering to obtain filtrate), and mixing the filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 1: 1; adding 95% ethanol to make alcohol content reach 60%, standing, precipitating with ethanol for 24 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at 70 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃), so as to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing colla Corii Asini into small pieces, adding 10 times of purified water, heating to dissolve completely, and filtering;
(5) mixing ferrous gluconate and flavoring agent, adding 3 times of purified water, and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, sterilizing under heat and pressure (105 deg.C for 45min), and making into oral liquid.
Example 2: preparation of traditional Chinese medicine composition of astragalus, angelica and donkey-hide gelatin oral liquid
The formula is as follows: 12g of astragalus, 4.5g of angelica, 4.5g of prepared rehmannia root, 3.5g of codonopsis pilosula, 2.5g of donkey-hide gelatin, 0.25g of ferrous gluconate, 14g of white granulated sugar and a proper amount of purified water are prepared into 100 mL.
The preparation method comprises the following steps:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata, and radix Codonopsis with purified water twice (5 times of purified water for 3 hr for the first time, filtering to obtain filtrate, decocting the residue with 8 times of purified water for 2 hr for the second time, filtering to obtain filtrate), and mixing the filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 0.8: 1; adding 98% ethanol to make ethanol content reach 55%, standing, precipitating with ethanol for 20 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at 80 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃) to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing colla Corii Asini into small pieces, adding 8 times of purified water, heating to dissolve completely, and filtering;
(5) mixing ferrous gluconate and flavoring agent, adding 4 times of purified water, and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, sterilizing under heat and pressure (105 deg.C for 45min), and making into oral liquid.
Example 3: preparation of traditional Chinese medicine composition of astragalus, angelica and donkey-hide gelatin oral liquid
The formula is as follows: 12g of astragalus, 5.5g of angelica, 3.5g of prepared rehmannia root, 4.5g of codonopsis pilosula, 1.5g of donkey-hide gelatin, 0.35g of ferrous gluconate, 10g of white granulated sugar and a proper amount of purified water are prepared into 100 mL.
The preparation method comprises the following steps:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata, and radix Codonopsis with purified water twice (8 times of purified water for 1 hr for the first time, filtering to obtain filtrate, decocting the residue with 5 times of purified water for 3 hr for the second time, filtering to obtain filtrate), and mixing the filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 1.2: 1; adding 95% ethanol to make ethanol content reach 65%, standing for precipitating with ethanol for 30 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at 60 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃), so as to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing colla Corii Asini into small pieces, adding 12 times of purified water, heating to dissolve completely, and filtering;
(5) mixing ferrous gluconate and flavoring agent, adding 2 times of purified water, and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, sterilizing under heat and pressure (105 deg.C for 45min), and making into oral liquid.
Example 4: preparation of traditional Chinese medicine composition of astragalus, angelica and donkey-hide gelatin oral liquid
The formula is as follows: 12g of astragalus, 6g of angelica, 3g of prepared rehmannia root, 5g of codonopsis pilosula, 1g of donkey-hide gelatin, 0.2g of ferrous gluconate, 16g of white granulated sugar and a proper amount of purified water are prepared into 100 mL.
The preparation method comprises the following steps:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata, and radix Codonopsis with purified water twice (7 times of purified water for 2 hr for the first time, filtering to obtain filtrate, decocting residue with 7 times of purified water for 1 hr for the second time, filtering to obtain filtrate), and mixing the filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 0.9: 1; adding 90% ethanol to make ethanol content reach 65%, standing for 25 hr for precipitating with ethanol, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at 75 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃), so as to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing colla Corii Asini into small pieces, adding 9 times of purified water, heating to dissolve completely, and filtering;
(5) mixing ferrous gluconate and flavoring agent, adding 2.5 times of purified water, and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, sterilizing under heat and pressure (105 deg.C for 45min), and making into oral liquid.
Example 5: preparation of traditional Chinese medicine composition of astragalus, angelica and donkey-hide gelatin oral liquid
The formula is as follows: 12g of astragalus, 4g of angelica, 4.9g of prepared rehmannia root, 3g of codonopsis pilosula, 3g of donkey-hide gelatin, 0.4g of ferrous gluconate, 8g of white granulated sugar and a proper amount of purified water are prepared into 100 mL.
The preparation method comprises the following steps:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata, and radix Codonopsis with purified water twice (6 times of purified water for 2 hr for the first time, filtering to obtain filtrate, decocting the second residue with 5 times of purified water for 2 hr, filtering to obtain filtrate), and mixing the filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 1.1: 1; adding 96% ethanol to make alcohol content reach 62%, standing, precipitating with ethanol for 28 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at 65 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃) to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing colla Corii Asini into small pieces, adding 11 times of purified water, heating to dissolve completely, and filtering;
(5) mixing ferrous gluconate and flavoring agent, adding 3.5 times of purified water, and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, sterilizing under heat and pressure (105 deg.C for 45min), and making into oral liquid.
Example 6: astragalus and angelica donkey-hide gelatin oral liquidPreparation of Chinese medicinal composition
The formula is as follows: 12g of astragalus, 5g of angelica, 4g of prepared rehmannia root, 4g of codonopsis pilosula, 2g of donkey-hide gelatin, 0.32g of ferrous gluconate, 12g of white granulated sugar and a proper amount of purified water are prepared into 100 mL.
The preparation method comprises the following steps:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata, and radix Codonopsis with purified water twice (6.5 times of purified water for 2.5 hr for the first time, filtering to obtain filtrate, decocting residue with 7.5 times of purified water for 1.5 times, filtering to obtain filtrate), and mixing the filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 1: 1; adding 97% ethanol to make ethanol content reach 60%, standing, precipitating with ethanol for 26 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at 70 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃), so as to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing colla Corii Asini into small pieces, adding 11 times of purified water, heating to dissolve completely, and filtering;
(5) mixing ferrous gluconate and flavoring agent, adding 4 times of purified water, and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, sterilizing under heat and pressure (105 deg.C for 45min), and making into oral liquid.
Example 7: preparation of traditional Chinese medicine composition of astragalus, angelica and donkey-hide gelatin oral liquid
The formula is as follows: 12g of astragalus, 5g of angelica, 4g of prepared rehmannia root, 4g of codonopsis pilosula, 2g of donkey-hide gelatin, 0.32g of ferrous gluconate, 12g of white granulated sugar and a proper amount of purified water are prepared into 100 mL.
The preparation method comprises the following steps:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata, and radix Codonopsis with purified water twice (7 times of purified water for 1 hr for the first time, filtering to obtain filtrate, decocting residue with 6.5 times of purified water for 1.5 hr for the second time, filtering to obtain filtrate), and mixing the filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 0.9: 1; adding 98% ethanol to make ethanol content reach 65%, standing, precipitating with ethanol for 24 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at 75 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃), so as to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing colla Corii Asini into small pieces, adding 8 times of purified water, heating to dissolve completely, and filtering;
(5) mixing ferrous gluconate and flavoring agent, adding 4 times of purified water, and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, sterilizing under heat and pressure (105 deg.C for 45min), and making into oral liquid.
Example 8: preparation of traditional Chinese medicine composition of astragalus, angelica and donkey-hide gelatin oral liquid
The formula is as follows: 12g of astragalus, 5g of angelica, 4g of prepared rehmannia root, 4g of codonopsis pilosula, 2g of donkey-hide gelatin, 0.32g of ferrous gluconate, 12g of white granulated sugar and a proper amount of purified water are prepared into 100 mL.
The preparation method comprises the following steps:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata, and radix Codonopsis with purified water twice (5 times of purified water for 3 hr for the first time, filtering to obtain filtrate, decocting residue with 6 times of purified water for 2 hr for the second time, filtering to obtain filtrate), and mixing the filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 0.9: 1; adding 95% ethanol to make the alcohol content reach 60%, standing and precipitating with ethanol for 20-30 hours, taking supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at 76 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃) to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing colla Corii Asini into small pieces, adding 11 times of purified water, heating to dissolve completely, and filtering;
(5) mixing ferrous gluconate and flavoring agent, adding 3 times of purified water, and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, sterilizing under heat and pressure (105 deg.C for 45min), and making into oral liquid.
Example 9: preparation of traditional Chinese medicine composition of astragalus, angelica and donkey-hide gelatin oral liquid
The formula is as follows: 12g of astragalus, 5g of angelica, 4g of prepared rehmannia root, 4g of codonopsis pilosula, 2g of donkey-hide gelatin, 0.32g of ferrous gluconate, 12g of white granulated sugar and a proper amount of purified water are prepared into 100 mL.
The preparation method comprises the following steps:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata, and radix Codonopsis with purified water twice (7 times of purified water for 2 hr for the first time, filtering to obtain filtrate, decocting the second residue with 8 times of purified water for 1.5 hr, filtering to obtain filtrate), and mixing the filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 1: 1; adding 95% ethanol to make alcohol content reach 60%, standing, precipitating with ethanol for 20 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at a temperature of 68 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃), so as to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing colla Corii Asini into small pieces, adding 9 times of purified water, heating to dissolve completely, and filtering;
(5) mixing ferrous gluconate and flavoring agent, adding 2 times of purified water, and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, sterilizing under heat and pressure (105 deg.C for 45min), and making into oral liquid.
Example 10: preparation of traditional Chinese medicine composition of astragalus, angelica and donkey-hide gelatin oral liquid
Referring to the formulation and preparation method of examples 1 to 9, respectively, except that sodium citrate (the weight ratio of astragalus root and sodium citrate is 12: 0.1) and sorbitol (the weight ratio of astragalus root and sorbitol is 12: 0.5) are further added to the filtrate obtained in step (2), and then the reduced pressure recovery of ethanol and concentration operation of step (4) are performed to obtain 9 batches of oral liquids, which can be referred to as samples of example 101 and example 102 … …, respectively, in sequence, and example 109.
Clinical trial example: the two oral liquids of example 1 and example 101 were used for 120 and 90 subjects with anemia, respectively, and both of them gave complete curative effects, and the oral liquid of example 211 also showed excellent effects. The specific test is as follows. 210 clinically confirmed anemia patients in 3-2016-7 months in 2014 are selected as study objects, divided into 120 cases in the example 1 group and 90 cases in the example 101 group, and respectively given oral liquids in the example 1 and the example 101; in addition, 107 clinically confirmed anemia patients 2015 to 2018 and 9 months were selected as the study subjects of the example 211 group, the test methods and the stripsThe same as in example 1 and example 101, which were given in example 211 was an oral liquid. In three groups of experiments, the oral liquid of the corresponding embodiment is orally taken by the subjects every day, the oral liquid is equivalent to 64mg of ferrous gluconate, the administration is divided into two times, and each subject is respectively and continuously taken for 12 weeks; example 1 group male-female ratio 51:69, age 33-54 years, mean (40.43 ± 5.38) years, degree of anemia: 24 cases with mild, 67 cases with moderate and 29 cases with severe; example 101 group of men and women at a ratio of 36:54, age 38-59 years, mean (42.43 ± 4.64) years, degree of anemia: mild 19, moderate 53, severe 18; example 211 group male-female ratio 42:65, age 36-52 years, mean (44.14 ± 4.16) years, degree of anemia: 27 cases with mild, 55 cases with moderate and 25 cases with severe; the difference between the three groups of age and sex has no statistical significance (P is more than 0.05). Observing and comparing three groups of curative effects and life quality conditions, including hemoglobin (Hb), Red Blood Cells (RBC), Hematocrit (HCT) and the like, wherein Hb indexes are as follows: the mild degree is more than 90g/L, the moderate degree is 60-90 g/L, and the severe degree is less than 30 g/L; the score is given by a quality of life assessment table (GQOL-74), including physiological function, social function, mental condition and the like, the total score is 100 points, and the score is in direct proportion to the curative effect. The data are analyzed by statistical software of SPSS 20.0, the measured data are expressed by x +/-s, and t test is adopted; the counting data are expressed as examples (n), percentages (%), and the difference is statistically significant when P <0.05 is used as an x2 test. The three groups of subjects showed complete cure effect in Hb, RBC, HCT and other indexes compared with those before treatment, and the improvement degree of the example 101 group and the example 211 group is better than that of the example 1 group, but the difference is not statistically significant (P)>0.05). The specific results are as follows: hb (g/L), RBC (. times.10) of group of example 112The three parameters of/L) and HCT (%) are 73.86 +/-4.83, 2.71 +/-0.23 and 22.58 +/-2.55 before treatment and 89.43 +/-3.48, 3.32 +/-0.27 and 32.71 +/-3.82 after treatment; example 101 group Hb (g/L), RBC (. times.10)12The three parameters of the concentration,/L) and HCT (%) are 71.91 +/-6.25, 2.67 +/-0.18 and 21.37 +/-2.32 before treatment and 93.57 +/-4.35, 3.38 +/-0.43 and 33.16 +/-4.36 after treatment; example 211 Hb (g/L), RBC (. times.10) of group12The three parameters of/L) and HCT (%) are 74.14 +/-5.42, 2.56 +/-0.26 and 23.42 +/-3.53 before treatment and 94.83 +/-4.76, 3.26 +/-0.17 and 36.16 +/-4 after treatment.64. Comparison of GQOL-74 score indices for three groups of subjects: the physiological function (76.47 +/-3.85), the social function (79.92 +/-5.24) and the mental condition (83.88 +/-4.45) of the group in the example 1, the physiological function (79.34 +/-4.25), the social function (84.21 +/-2.77) and the mental condition (85.62 +/-5.47) of the group in the example 101, the physiological function (78.63 +/-3.17), the social function (83.87 +/-3.83) and the mental condition (87.66 +/-4.04) of the group in the example 101; as can be seen, the GQOL-74 score values of the example 101 and example 211 groups were superior to the example 1 group, but the differences were not statistically significant (P)>0.05). In addition, according to statistics, 4-9 constipation reports are reported in part of the subjects (distributed in the example 1 group and the example 101 group) within the taking period of 12 weeks, each group is counted by the average constipation occurrence frequency of each person within 12 weeks (namely the quotient of the sum of the reported times of all the subjects in each group divided by the total number of the persons), 1.74 constipation reports are reported in the example 1 group, 1.62 constipation reports in the example 101 group, and 0.13 constipation reports in the example 211 group, which shows that the probability of the adverse reaction of the composition in the example 211 is greatly reduced.
Test example 1: the oral liquid obtained in various embodiments of the invention is respectively measured for typical component content according to a method of corresponding medicinal material varieties in the first part of the 2015 edition of Chinese pharmacopoeia, and the measured target substances comprise: astragalus (determination of astragaloside IV and calycosin glucoside), prepared rehmannia root (determination of verbascoside), angelica (determination of ferulic acid), and codonopsis pilosula (determination of codonopsis pilosula alkynoside by RP-HPLC method, wherein the determination method comprises the steps of Rong-run and the like, analysis of content of codonopsis pilosula alkynoside in Shanxi codonopsis pilosula medicinal materials, journal of drug analysis, 2007 stage 08).
Test example 2: high temperature treatment test: the oral liquid prepared in the various embodiments of the present invention is placed at a temperature of 40 ℃ for 6 months (which may be referred to as a high-temperature 6-month treatment), observed/measured/calculated at 6 months for the presence or absence of precipitate formation, and the change of the content of the four types of measurement targets with respect to 0 months thereof (expressed as a relative percentage, i.e., a percentage of the content of 6 months with respect to the content of 0 months) as described in test example 1.
The initial state results after preparation show that 9 batches of oral liquids obtained in example 10 are basically the same as the four types of determination targets of the corresponding oral liquids in examples 1 to 9 in the initial state, and no difference is found, specifically, the content of the four types of determination targets of the oral liquid in example 10 is within 98.3-103.2% of the content of corresponding substances of the oral liquids in corresponding examples 1 to 9, for example, the oral liquid in example 1 is not different from the oral liquid in example 101 in the content of the four types of measurement target substances, the content of the four types of measurement target substances in the oral liquid in example 101 is within 99.6-102.3% of the content of the corresponding substances in the oral liquid in example 1, for example, the content of calycosin glucoside in the oral liquid of example 101 is 100.7% of that of calycosin glucoside in the oral liquid of example 1, indicating that the four types of measurement targets are substantially the same in the initial state of the oral liquid obtained under the two formulation/preparation conditions. In addition, the oral liquid obtained in each of examples 1 to 10 was a clear solution after preparation, and no precipitate was observed.
The results of the high temperature treatment test showed that, at 6 months, all the oral liquids of examples 1 to 9 had precipitates of different degrees in the properties of the oral liquid, and were suspended after shaking; in contrast, all nine oral solutions of example 10 had no precipitate and remained as a clear solution.
In the aspect of the change of chemical components of the oral liquid in a high-temperature treatment test, except calycosin glucoside, the contents of other measured target substances of different oral liquids are not obviously changed in 0 month relative to the sample, the 6-month content of each three types of target substances of each oral liquid is 97.2-99.6% of the 0-month content of the corresponding target substance of the corresponding oral liquid, for example, the 6-month content of the oral liquid in example 1 is 98.3% of the 0-month content of astragaloside; however, the different oral liquid samples showed different changes at 6 months, characterized by the relative percentage of calycosin glucoside at 6 months (relative to the relative percentage at 0 months, i.e. the percentage obtained by dividing the concentration at 6 months by the concentration at 0 months and multiplying by 100%), all the oral liquids of examples 1-9 ranged from 84-88%, while all the oral liquids of example 10 ranged from 98.2-99.8%, which is significantly higher than those of examples 1-9, e.g. 86.3% for example 1 and 98.7% for example 101.
Example 21: referring to the formulation and preparation method of nine samples of example 10, example 101 and example 102 … …, example 109 respectively, except that sodium citrate is replaced by sodium tartrate, sorbitol is replaced by glycine, and the medicinal materials are astragalus: sodium tartrate: the weight ratio of glycine is 12: 0.25: 0.75, 9 oral liquid samples are prepared, which can be respectively referred to as example 211 and example 212, 212 … … and example 219 in sequence.
The oral liquid obtained in example 21 was free from precipitates at the beginning of the test conducted in accordance with the methods of test examples 1 and 2.
The 9 batches of oral liquid obtained in example 21 are respectively basically the same as the 9 corresponding batches of oral liquid in example 10 in the initial state of the four types of determination targets, and no difference is seen, specifically, the four types of determination targets of the oral liquid in example 21 are in the range of 98.8-102.7% of the corresponding substances of the oral liquid in example 10, for example, the oral liquid in example 211 is not different from the oral liquid in example 101 in the content of the four types of determination targets, the four types of determination targets of the oral liquid in example 211 are in the range of 99.2-101.6% of the corresponding substances of the oral liquid in example 101, for example, the content of calycosin glucoside in the oral liquid in example 211 is 99.6% of the content of calycosin glucoside in the oral liquid in example 101, which shows that the four types of determination targets of the oral liquid obtained in the two formula/preparation conditions are basically the same in the initial state. In addition, the oral liquid obtained in example 21 was a clear solution after the preparation, and no precipitate was observed. After 6 months of the high temperature treatment test, no precipitate was observed in all nine oral liquids of example 21, and the state of the clear solution was maintained. After 6 months of the high temperature treatment test, in terms of the change of chemical components of the oral liquid, the 6-month content of each of the four types of target substances in all nine oral liquids in example 21 is in the range of 98.4 to 100.2% of the 0-month content of the corresponding target substance in the oral liquid, for example, the 6-month content of the oral liquid in example 211 is 99.7% of the 0-month content in case of astragaloside, and the 6-month content of the oral liquid in example 212 is 99.1% of the 0-month content in case of calycosin glucoside, which indicates that all nine oral liquids in example 21 exhibit excellent stability in all respects similar to all nine oral liquids in example 10.
Test example 3: filtration and viscosity test
Although the oral liquids of example 10 and example 21 are substantially identical in chemical properties, particularly in stability, the present inventors have found that, in the step (6) of preparing the injection liquid, the liquid medicine of different formulations exhibits significant differences that may be associated with the components in the formulations when the liquid medicine is subjected to final filtration. Specifically, in the step (6), the liquid medicine is filtered by using a microporous membrane filter (polytetrafluoroethylene membrane with a diameter of 100mm, a pore diameter of 0.5um and a filtering pressure of 0.3Mpa), each prescription is filtered by using the same parameters recommended by the filter, 10L of liquid medicine is filtered each time, the relative filtering time of the oral liquid in the step (6) in the final filtering is recorded by using the filtering time of the injection water with the same volume/temperature (26-28 ℃) as a comparison, and the results show that the relative filtering time of the nine oral liquids in the example 10 is 2.14-2.27, the relative filtering time of the nine oral liquids in the example 21 is 1.31-1.35, for example 101 is 2.25, and the relative filtering time of the example 211 is 1.32. In addition, when the viscosities of the oral liquids of examples 10 and 21 (relative viscosities to water for injection at the same temperature (22 ℃) were measured), the relative viscosities of the nine oral liquids of example 10 were 1.53 to 1.68, the relative filtration times of the nine oral liquids of example 21 were 1.13 to 1.17, the relative filtration times of example 102 were 1.64, and the relative filtration time of example 212 was 1.14, and it was found that the viscosity of the drug solution and the ease of filtration were correlated with each other. As can be seen from the results of the test examples, the oral liquid of example 21 has more excellent process adaptability.
Example 22: referring to example 21, except that sodium tartrate is added in the corresponding steps instead of glycine, all the obtained oral liquids have different degrees of precipitates after the same high-temperature treatment for 6 months, and are suspended after shaking, and the relative percentage content of calycosin glucoside in 6 months is 81-85%; for example, referring to the formulation process of example 211, except that no glycine was added, the obtained oral liquid contains calycosin glucoside 83.2% in a relative percentage of 6 months.
Example 23: referring to example 21, except that glycine was added in the corresponding steps without adding sodium tartrate, all the obtained oral liquids had different degrees of precipitates after the same high temperature treatment for 6 months, and were suspended after shaking, and the relative percentage content of calycosin glucoside 6 months was 83-85%; for example, referring to the formulation process of example 212, except that sodium tartrate is not added, the obtained oral liquid contains acteoside in 81.6% in relative percentage of 6 months.
Example 24: referring to example 21, except that sodium tartrate and glycine are added before the first decoction in step (1), the obtained oral liquid is treated at the same high temperature for 6 months, so that all the oral liquid have precipitates with different degrees, and are in a suspension state after shaking, and the relative percentage content of calycosin glucoside in 6 months is 84-87%; for example, the formulation process of reference example 213 is only to add sodium tartrate and glycine before the first decoction in step (1), and the obtained oral liquid contains 84.1% of calycosin glucoside 6 months relative. The results of examples 22-24 above show that oral solutions without the simultaneous addition of sodium tartrate and glycine in a particular process step are unacceptable in one/some aspects.
Test example 4: investigation of effects of improving qi and blood functions of human body and delaying aging of human body
As mentioned herein, qi deficiency manifests as exercise asthma, exercise palpitation, while blood deficiency manifests as sallow complexion, whitish complexion, dizziness, palpitation, poor sleep; the obvious appearance of aging is as follows: poor physical strength, easy insomnia, hearing loss, heavy taste, high blood pressure, alopecia, etc. In the experiment, the oral liquid obtained in the embodiment 211 of the invention is used for inspecting the effect of the composition of the invention on improving the qi and blood functions of the human body and delaying the aging of the human body. 146 subjects who were included in the test, 53 men, 93 women, and 38 to 57 years old were evaluated by observation, inquiry, and complaint in combination during the 1 month period before the start of the test, and among the 146 subjects, 131 patients with qi deficiency, 108 patients with blood deficiency, and 124 patients with aging. The subject takes the oral liquid 211 of the present invention equivalent to 64mg of ferrous gluconate every day, and the oral liquid is administered twice, each subject takes the oral liquid for 12 weeks continuously, and the diet and daily life during the taking period are maintained the same as before the administration. After the administration is finished, through observation, inquiry and self-complaint combination and comprehensive evaluation, 2 people with unchanged qi deficiency performance and disappearance of qi deficiency of other people (the obvious improvement rate of qi deficiency reaches 98.5%), 7 people with unchanged blood deficiency performance and disappearance of blood deficiency of other people (the obvious improvement rate of blood deficiency reaches 93.5%), 6 people with unchanged aging performance and remarkably reduced aging performance of other people (the aging delay rate reaches 95.2%). These results show that the composition of the present invention has excellent effects of improving qi and blood functions of human body and delaying aging of human body.
Test example 5: examination of Effect of hypoxia tolerance
Experiments were performed with reference to the old cuckoo literature (old cuckoo, et al, study of the hypoxia tolerance of mice by extracts of Tibetan polo flowers, Sichuan animals, 2012, 31 (1)). Experimental mice were randomized into groups of 10 mice each and were administered intragastrically. The test results were divided into a blank control group, a positive control group (propranolol hydrochloride), example 211, example 212, and example 101 oral liquid groups. The administration dose for each group by intragastric administration is as follows: a blank control group (0.5% CMC-Na solution, 0.1mL/10g), a positive control group (propranolol hydrochloride, 0.03g/kg), and a test group (oral liquid is equivalent to 10mg/kg of ferrous gluconate). The positive drug and the test group are both prepared into a certain concentration by 0.5 percent CMC-Na solution, and are administrated by intragastric administration with the volume of 0.1mL/10g, once a day, continuously administrated for 7 days, and the hypoxia tolerance experiment is carried out after the last administration for 1 h.
Normal pressure hypoxia-resistant experiment: a250 mL ground jar was selected, the volume was adjusted with distilled water beforehand, and 10g soda lime was placed at the bottom of the jar to absorb moisture and carbon dioxide. After the last administration for 1h, the mice are placed in a bottle, vaseline is coated on the bottle mouth, the bottle cap is tightly sealed to cause airtight hypoxia, timing is carried out immediately, the cessation of breathing is taken as an indication of death, and the time of hypoxia asphyxia death of the mice is recorded. Sodium nitrite poisoning survival experiment: after 1h of the last administration, mice were intraperitoneally injected with sodium nitrite (0.1mL/10g) at a dose of 200mg/kg, immediately timed, and mice were recorded for toxic survival time with cessation of breathing as an indication of death. Acute cerebral ischemic hypoxia experiment: 1h after the last administration, the lower part of the ear of the mouse is rapidly broken, the time is immediately counted, the mouse stops breathing as the death indication, and the survival time is recorded. All data were statistically processed using SPSS10.0 software, experimental data were expressed as means. + -. standard deviation (x. + -.s), and group comparisons were by t-test, with statistical differences at P < 0.05.
The results of the mouse normal-pressure hypoxia tolerance experiment: compared with a blank control group, the positive control group, the example 211, the example 212 and the example 101 oral liquid group can obviously prolong the survival time of the mice under the condition of normal pressure and oxygen deficiency, and specifically comprise the following steps: the survival times (min) of the blank control group, the positive control group, example 211, example 212, and example 101 oral liquid group were 18.62 ± 1.68, 24.76 ± 1.84, 23.11 ± 2.02, 22.84 ± 1.42, and 21.06 ± 1.92, respectively (where P <0.05, P <0.01, compared to the blank control group). Survival experimental results for mouse sodium nitrite poisoning: compared with a blank control group, the positive control group and each embodiment group can obviously prolong the survival time of the mice under the sodium nitrite poisoning condition, and the method specifically comprises the following steps: the survival times (min) of the blank control group, the positive control group, example 211, example 212, and example 101 oral liquid group were 19.37 ± 1.75, 23.54 ± 1.96, 23.06 ± 1.84, 24.11 ± 2.23, and 21.87 ± 1.84, respectively (where P <0.05, P <0.01, compared to the blank control group). The experimental result of the acute cerebral ischemic hypoxia of the mouse is as follows: compared with a blank control group, the positive control group and each embodiment group can obviously prolong the duration of mouth-opening gasping of the mice after decapitation, and the specific steps are as follows: the survival times (min) of the blank control group, the positive control group, example 211, example 212, and example 101 oral liquid group were 19.57 ± 2.03, 23.73 ± 1.87, 23.32 ± 1.94, 22.96 ± 2.11, and 22.01 ± 2.52, respectively (where P <0.05, P <0.01 compared to the blank control group).
Test example 6: test for Effect of the composition on inhibiting tumor cell growth
The invention performs the following tumor cell growth inhibition tests: reference is made to the Cantonella (Cantonella, et al, 20(s) -protopanaxadiol, ginsenoside Rh2And ginsenoside Rg3Comparison of antitumor effects, journal of china geriatrics, 2014, stage 17), the antitumor effects of the compositions of example 1, example 101 and example 215 of the present invention were studied by conducting experiments based on drug non-clinical study quality management criteria (GLP), by establishing three transplanted tumor animal models of mouse liver cancer H22, Lewis lung cancer and melanoma B16, mice were randomly grouped, a control group was given water of the same volume as the oral liquid, a positive drug group was given Cyclophosphamide (CTX) prepared with water for injection at 30mg/kg, the daily dose of the oral liquid group of example 1 was 2mg/kg body weight calculated as iron, the daily dose of the oral liquid group of example 101 was 2mg/kg body weight calculated as iron, and the daily dose of the oral liquid group of example 215 was 2mg/kg body weight calculated as iron. The positive medicine is administrated by intraperitoneal injection every other day for 1 time, and the rest groups are administrated by intragastric administration for 1 time every day for 10 days continuously; the weight of the mice is recorded every day, and the weight of the mice and the weight of the tumor are weighed after the last dose is taken, and the tumor inhibition rate is calculated. As a result, for the H22 liver cancer tumor-bearing mouse model: the average body weight of each group of animals before administration is within the range of 19.5-19.9 g (for example, the average body weight of a control group is 19.68 g); after administration, the average body weight of the control group is 24.62g, the average body weight of the positive drug group is 19.33g, and the average body weights of the three oral liquid groups of example 1, example 101 and example 215 are 22.76g, 22.43g and 22.14g respectively; the average tumor weight of the control group was 1.23g, and the tumor inhibition rates of the positive drug group and the three oral liquid groups were 83.24%, 22.27%, 27.11% and 35.16%, respectively, which shows that the composition of the present invention exhibits a certain tumor inhibition effect, and the example 215 oral liquid has a better tumor inhibition effect than the other two oral liquid groups. For Lewiss lung cancer tumor-bearing mouse model: the average body weight of each group of animals before administration is within the range of 19.4-19.7 g (for example, the average body weight of a control group is 19.53 g); after administration, the average body weight of the control group is 23.68g, the average body weight of the positive drug group is 18.56g, and the average body weights of the three oral liquid groups of example 1, example 101 and example 215 are 20.52g, 20.56g and 20.74g respectively; the average tumor weight of the control group was 1.07g, and the tumor inhibition rates of the positive drug group and the three oral liquid groups were 76.35%, 28.44%, 32.61% and 37.53%, respectively, and the results showed that the composition of the present invention exhibited a certain tumor inhibition effect, and the example 215 oral liquid had a better tumor inhibition effect than the other two oral liquid groups. Mouse model for melanoma B16 tumor bearing: the average body weight of each group of animals before administration is within the range of 19.5-19.7 g (for example, the average body weight of a control group is 19.61 g); after administration, the average body weight of the control group is 23.75g, the average body weight of the positive drug group is 18.83g, and the average body weights of the three oral liquid groups of example 1, example 101 and example 215 are 21.57g, 20.87g and 21.25g respectively; the average tumor weight of the control group was 1.22g, and the tumor inhibition rates of the positive drug group and the three oral liquid groups were 78.45%, 24.37%, 27.53% and 34.31%, respectively, which shows that the composition of the present invention exhibits a certain tumor inhibition effect, and the example 215 oral liquid has a better tumor inhibition effect than the other two oral liquid groups. The above results show that the composition of the present invention has growth inhibitory effects on liver cancer, lung cancer and melanoma, and although the inhibitory effects are worse than those of the classical chemical drugs in pharmacodynamics, it is expected that the antitumor effects of the oral liquid are expected to be improved by changing, for example, increasing the dosage; on the other hand, the oral liquid of the invention does not cause the weight loss of animals, which is the common side effect of the anticancer drug.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.

Claims (10)

1. Use of a Chinese medicinal composition or a Chinese medicinal composition according to any one of claims 2 to 9 in the preparation of a product for inhibiting tumor cell growth, preventing and treating cancer, wherein the Chinese medicinal composition is prepared from astragalus membranaceus, angelica sinensis, radix rehmanniae preparata, codonopsis pilosula, donkey-hide gelatin, ferrous gluconate and optionally a pharmaceutical adjuvant.
2. A Chinese medicinal composition comprises radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata, radix Codonopsis, colla Corii Asini, ferrous gluconate and optional medicinal adjuvants.
3. The Chinese medicinal composition according to claim 2, which is prepared from 1200 parts by weight of astragalus, 400 to 600 parts by weight of angelica, 300 to 500 parts by weight of prepared rehmannia root, 300 to 500 parts by weight of codonopsis pilosula, 100 to 300 parts by weight of donkey-hide gelatin, 20 to 40 parts by weight of ferrous gluconate and optionally pharmaceutical excipients; or,
the traditional Chinese medicine composition is prepared from 1200 parts by weight of astragalus membranaceus, 410-600 parts by weight of angelica sinensis, 300-500 parts by weight of prepared rehmannia root, 300-500 parts by weight of codonopsis pilosula, 100-300 parts by weight of donkey-hide gelatin, 20-40 parts by weight of ferrous gluconate and optional pharmaceutical excipients; or,
the traditional Chinese medicine composition is prepared from 1200 parts by weight of astragalus membranaceus, 450-550 parts by weight of angelica sinensis, 350-450 parts by weight of prepared rehmannia root, 350-450 parts by weight of codonopsis pilosula, 150-250 parts by weight of donkey-hide gelatin, 25-35 parts by weight of ferrous gluconate and optional pharmaceutical auxiliary materials; or,
it is prepared from 1200 parts by weight of astragalus root, 500 parts by weight of angelica, 400 parts by weight of prepared rehmannia root, 400 parts by weight of codonopsis pilosula, 200 parts by weight of donkey-hide gelatin, 32 parts by weight of ferrous gluconate and optional pharmaceutical excipients.
4. The Chinese medicinal composition according to claim 2, which is a liquid preparation in the form of an oral liquid.
5. The traditional Chinese medicine composition according to claim 2, which is a liquid medicament in the form of an oral liquid, and is prepared by using 8-16 g of astragalus root medicinal material per 100 ml; or,
the preparation is a liquid medicament in the form of oral liquid, and the amount of astragalus root used per 100ml is 10-14 g; or,
it is a liquid preparation in the form of oral liquid, and is prepared by using 12g of astragalus root medicinal material per 100 ml.
6. The traditional Chinese medicine composition according to claim 2, wherein the pharmaceutical excipient comprises a flavoring agent; for example, the flavoring agent is a sweetener, such as aspartame, acesulfame potassium, saccharin sodium, sucrose.
7. The Chinese medicinal composition according to claim 2, which is a liquid medicament in the form of an oral liquid, prepared by a method comprising the steps of:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata and radix Codonopsis with purified water twice (for example, decocting 5-8 times (for example, 6 times) of purified water for 1-3 hr (for example, 2 hr), filtering to obtain filtrate, decocting the second residue with 5-8 times (for example, 6 times) of purified water for 1-3 hr (for example, 2 hr), filtering to obtain filtrate), and mixing the two filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 0.8-1.2: 1, such as 1: 1; adding ethanol (such as ethanol with concentration of 90% or more or 95% or more) to make ethanol content reach 55-65% (such as ethanol content reach 60%), standing for precipitating with ethanol for 20-30 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at the temperature of 60-80 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃) to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing donkey-hide gelatin into small pieces, adding 8-12 times, for example, 10 times of purified water, heating to completely dissolve the donkey-hide gelatin, and filtering for later use;
(5) mixing ferrous gluconate and optional flavoring agent (such as sucrose), adding 2-4 times of purified water (such as 3 times of purified water), and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, and sterilizing under hot pressure (such as 105 deg.C for 45 min).
8. The Chinese medicinal composition according to claim 2, wherein the pharmaceutical excipients further comprise sodium citrate and sorbitol; for example, the weight ratio of the medicinal materials astragalus root and sodium citrate is 12: 0.1; for example, the weight ratio of the medicinal materials astragalus root and sorbitol is 12: 0.5; for example, sodium citrate and sorbitol are added to the filtrate obtained in step (2).
9. The Chinese medicinal composition according to claim 2, wherein the pharmaceutical excipients further comprise sodium tartrate and glycine; for example, the weight ratio of the medicinal materials astragalus root and sodium tartrate is 12: 0.25; for example, the weight ratio of the medicinal materials of astragalus and glycine is 12: 0.75; for example, sodium tartrate and glycine are added to the filtrate obtained in step (2).
10. A process for preparing a Chinese medicinal composition as claimed in any one of claims 2 to 9, comprising the steps of:
(1) decocting radix astragali, radix Angelicae sinensis, radix rehmanniae Preparata and radix Codonopsis with purified water twice (for example, decocting 5-8 times (for example, 6 times) of purified water for 1-3 hr (for example, 2 hr), filtering to obtain filtrate, decocting the second residue with 5-8 times (for example, 6 times) of purified water for 1-3 hr (for example, 2 hr), filtering to obtain filtrate), and mixing the two filtrates;
(2) concentrating the combined filtrate under reduced pressure until the weight ratio of the liquid medicine to the medicinal materials is 0.8-1.2: 1, such as 1: 1; adding ethanol (such as ethanol with concentration of 90% or more or 95% or more) to make ethanol content reach 55-65% (such as ethanol content reach 60%), standing for precipitating with ethanol for 20-30 hr, collecting supernatant, and filtering to obtain filtrate;
(3) recovering ethanol from the filtrate obtained in the step (2) at the temperature of 60-80 ℃ under reduced pressure until no alcohol smell exists, and concentrating the alcohol-free liquid under reduced pressure until the relative density is 1.05-1.08 (the measurement temperature is 40 ℃) to obtain a traditional Chinese medicine extracting solution for later use;
(4) smashing donkey-hide gelatin into small pieces, adding 8-12 times, for example, 10 times of purified water, heating to completely dissolve the donkey-hide gelatin, and filtering for later use;
(5) mixing ferrous gluconate and optional flavoring agent (such as sucrose), adding 2-4 times of purified water (such as 3 times of purified water), and heating for dissolving;
(6) mixing the above medicinal liquids of steps (3), (4) and (5), mixing, adding purified water to desired volume, stirring, filtering, packaging, sealing, and sterilizing under hot pressure (such as 105 deg.C for 45 min).
CN201910214558.2A 2019-03-20 2019-03-20 For inhibiting the Chinese medicine composition of growth of tumour cell prophylactic treatment cancer Withdrawn CN109731045A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910214558.2A CN109731045A (en) 2019-03-20 2019-03-20 For inhibiting the Chinese medicine composition of growth of tumour cell prophylactic treatment cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910214558.2A CN109731045A (en) 2019-03-20 2019-03-20 For inhibiting the Chinese medicine composition of growth of tumour cell prophylactic treatment cancer

Publications (1)

Publication Number Publication Date
CN109731045A true CN109731045A (en) 2019-05-10

Family

ID=66371121

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910214558.2A Withdrawn CN109731045A (en) 2019-03-20 2019-03-20 For inhibiting the Chinese medicine composition of growth of tumour cell prophylactic treatment cancer

Country Status (1)

Country Link
CN (1) CN109731045A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101342271A (en) * 2008-09-08 2009-01-14 张立莲 Traditional Chinese medicine for treating qi-blood deficiency caused by tumour chemotherapy and preparation method thereof
CN107929420A (en) * 2017-11-23 2018-04-20 江西天元药业有限公司 Improve energy and blood of human body function and improve the Chinese medicine composition and detection method of immunity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101342271A (en) * 2008-09-08 2009-01-14 张立莲 Traditional Chinese medicine for treating qi-blood deficiency caused by tumour chemotherapy and preparation method thereof
CN107929420A (en) * 2017-11-23 2018-04-20 江西天元药业有限公司 Improve energy and blood of human body function and improve the Chinese medicine composition and detection method of immunity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周长芳等: "中西医结合治疗中晚期非小细胞肺癌21例临床观察 ", 《江苏中医药》 *

Similar Documents

Publication Publication Date Title
CN107929420B (en) Traditional Chinese medicine composition for improving qi and blood functions and immunity of human body and detection method
CN103860969A (en) Traditional Chinese medicine for increasing weight
CN104352887A (en) Anti-tumor comprehensive conditioning cream and preparing technology thereof
CN105454576A (en) Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof
CN109718303A (en) Improving the skin maintenance and cosmetic benefits of female ovary function improves the Chinese medicine composition of female skin
CN105232911A (en) Traditional Chinese medicine composition
CN104398991A (en) Medicinal composition for treating hypogalactia symptom of dairy cow and preparation method thereof
CN104223297B (en) A kind of schisandra chinensis health-care oral liquid of slow down aging and preparation method thereof
CN117599140A (en) Traditional Chinese medicine composition for reducing blood sugar, blood pressure and blood fat and preparation and application thereof
CN107519310A (en) Improve Chinese medicine composition and preparation technology that energy suppresses growth of tumour cell function
CN106215118A (en) Antineoplastic health preparation and preparation method thereof
CN109718304A (en) Improve the Chinese medicine composition of the microcirculation of human body cardio and vascular function and pre- preventing thrombosis
CN113730514A (en) Compound wine composition beneficial to improving immunity and preparation method and using method thereof
CN108355052B (en) Medicine for treating leucopenia after radiotherapy and chemotherapy and preparation method and application thereof
CN109731045A (en) For inhibiting the Chinese medicine composition of growth of tumour cell prophylactic treatment cancer
CN111084878A (en) Biological medicine and medical total nutrient food for lung and respiratory system diseases and preparation method thereof
CN109718305A (en) Improve energy and blood of human body function and improves the Chinese medicine composition that resist oxygen lack delays senescence
CN104825864A (en) Health-care medicated diet having synergistic effect on radiotherapy and preparation method thereof
CN100529045C (en) Health preserving wine from prescription of the Yi nationality, and preparation method
CN104258224A (en) Schisandra chinensis oral solution for treating lung-and-kidney yin-deficiency type chronic bronchitis and preparation method thereof
CN109771510A (en) Adjust the Chinese medicine composition and preparation process of human body energy and equilibrium between yin and yang
CN109718302A (en) It treats adjusting and postpones the Chinese medicine composition of female climacteric syndrome
CN109731046A (en) Improve the Chinese medicine composition of the Chinese medicine composition of human body renal function enhancing human body kidney qi
CN108324783A (en) It is white to return ginseng Ling Donggan medicines for cancer
CN107468938A (en) A kind of formula of asparagus tea and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20190510